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I. INTRODUCTION
Portsmouth, Ohio is a small steel town with a big city problem.1 This city has
been particularly hard hit by the prescription drug abuse epidemic.2 Nationally, the
prescription abuse epidemic has killed more people than the crack cocaine epidemic
of the 1980’s and the heroin epidemic of the 1970’s combined.3 In 2010, “9.7
million doses of prescription painkillers were dispensed in Scioto County[, Ohio, or]
123 doses for each of the 79,000 men, women and children in the county.”4
Portsmouth counts its dead by lining the front window of a vacant department store
with pictures of those who died due to overdosing.5 The city is essentially raising
third and fourth generation prescription drug addicts.6 In one particularly
disheartening instance, a local family could name eleven houses on their street that
sold drugs.7 The majority of people who abuse these medications either get their
drugs from dealers on the street or from someone who has access to these drugs.8
The drug of choice—Oxycontin—is legal, and can be obtained from a local
pharmacy with a prescription.9 Drug abuse there is so pervasive that, despite the high
1
This Note frequently references Portsmouth, Ohio as a case study for the effects of
ineffective legislation currently controlling in Ohio.
2

Sabrina Tavernise, Ohio County Losing Its Young to Painkillers’ Grip, N.Y. TIMES
(Apr. 19, 2011), http://www.nytimes.com/2011/04/20/us/20drugs.html?_r=3&pagewanted=1;
see also STATE MEDICAL BOARD OF OHIO, RESOLUTION REGARDING PRESCRIPTION DRUG
ABUSE (2011), available at http://www.med.ohio.gov/pdf/PrescriptionDrug%20Abuse.pdf
(“Between 1999 and 2008, there was a 360% increase in accidental over-dose deaths in Scioto
County; 92% of these deaths are due to prescription medication.”).
3

See Tavernise, supra note 2.

4

See STATE MEDICAL BOARD, supra note 2; see also OHIO DEPARTMENT OF ALCOHOL
AND DRUG ADDICTION SERVICES, OHIO’S OPIATE EPIDEMIC: 2010 PRESCRIPTION OPIATE
CONSUMPTION PER CAPITA (2011), available at http://www.odadas.state.oh.us/public/
OpenFile.aspx?DocumentID=12f9370d-e022-48ee-ba0a-b688d21167a5 (documenting opiate
consumption per capita in each of Ohio’s counties; Scioto, Ohio has one of the highest rates of
opiate consumption).
5

See Tavernise, supra note 2.

6

See Tavernise, supra note 2.

7

See Tavernise, supra note 2; see also Prescription Drug Abuse – Prescription Drug
Addiction, ATLANTA RECOVERY CENTER, http://atlantarecoverycenter.com/drugs-ofabuse/prescription-drug-abuse/ (last visited Oct. 30, 2012) (explaining that Oxycontin is a
highly addictive prescription drug and is fatal when taken in large doses).
8

See Tavernise, supra note 2.

9

See Controlled Substances – Alphabetical Order, OFFICE OF DIVERSION CONTROL, DRUG
http://www.deadiversion.usdoj.gov/schedules
/orangebook/c_cs_alpha.pdf (last updated September 6, 2012) (listing Oxycodone, commonly
known as Oxycontin, as a “Schedule II” substance). Schedule II substances can be prescribed
by practitioners. Section V – Valid Prescription Requirements, OFFICE OF DIVERSION
CONTROL, DRUG ENFORCEMENT ADMIN, U.S. DEP’T OF JUSTICE, http://www.deadiversion
.usdoj.gov/pubs/manuals/pract/section5.htm (last visited Oct. 28, 2012).
ENFORCEMENT ADMIN, U.S. DEP’T OF JUSTICE,

2013]

PHARMAGEDDON: A STATUTORY SOLUTION

105

unemployment rate,10 some businesses have difficulty finding job candidates who
can pass a drug test.11
While some parts of Ohio are affected more so than others by this prescription
abuse epidemic,12 current legislation allows a situation, like that of Portsmouth, to
happen anywhere in Ohio. This is in large part due to Ohio’s statutory scheme that
focuses more on punishment than prevention, despite recent encouraging changes
that have been made.13 Despite the changes already in place, the legislature should
enact a consequential solution that prevents prescription abuse by removing these
drugs from the streets.
Ohio has a system in place with the capability to curb prescription drug abuse,
but it is far underutilized.14 The Ohio Automated Rx Reporting System (“OARRS”)
currently tracks all controlled prescription medications dispensed by an Ohiolicensed pharmacy.15 OARRS is “designed to allow physicians and pharmacists to
cross-check prescriptions with each other and identify individuals who may be
doctor shopping.”16 When using OARRS, physicians can more effectively serve as
the gatekeepers to dangerous prescription medications because they have access to
more information to make the best decisions regarding prescription choices for
patients.17 But, currently, reporting from the system is not required in all situations,
and before the recent changes of 2011, only a minority of practitioners were
10
Local Area Unemployment Statistics, UNITED STATES DEPARTMENT OF LABOR, available
at http://data.bls.gov/timeseries/LASST39000003 (Data extracted on Oct. 28, 2012) (Ohio’s
unemployment rate for August, 2012 was 7.2%).
11

See Tavernise, supra note 2.

12

See OHIO DEPARTMENT OF ALCOHOL AND DRUG ADDICTION SERVICES, supra note 4
(displaying opiate consumption per capita in each of Ohio’s counties). Although this map
accounts for all opiate consumption, legitimate and illegitimate, it can be inferred that the
incidence of illicit prescriptions would be more prevalent in areas with higher overall
incidence rates of opiate consumption. See id.
13
See infra Part II.E (discussing the current state of Ohio law relating to prescription
abuse, and the recent changes enacted by the Ohio Legislature to combat pill mills). See also
infra Part II.B (discussing the shortcomings of Ohio’s statutory system related to prescription
drug abuse and prevention).
14

Ohio Sheriffs' Group Seeks Better Drug Monitoring, THE COLUMBUS DISPATCH (Jan. 20,
2010) http://www.dispatch.com/content/stories/local/2010/01/20/drug-monitor.html
(reporting that before the recent changes in 2011, however, only 13% of Ohio’s 42,000
doctors and dentists were registered to use this system).
15

See Ohio Rev. Code Ann. § 4729.75 (LexisNexis 2011) (granting the Ohio Board of
Pharmacy authority to “establish and maintain a drug database . . . to monitor the misuse and
diversion of controlled substances”). Distributors of drugs include not only retail pharmacies
located within the state, but also mail order pharmacies located outside of the state. Ohio Rev.
Code Ann. § 4729.77 (LexisNexis 2011) (“each . . . terminal distributor of dangerous drugs
that dispenses drugs to patients in this state . . . shall submit to the board . . . prescription
information” including patient information, prescriber identification, and prescription
information such as drug, dosage, quantity, and days’ supply).
16

Doctor Shopping Chronic Pain Medication Addiction, DRUGADDITION.COM,
http://www.drug-addiction.com/doctor_shopping.htm (last visited Oct. 28, 2012).
17

See id.
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registered to use it.18 In response to the growing prescription drug abuse epidemic,
the Ohio legislature enacted House Bill 93 on May 20, 201119 to eliminate “pill
mills,”20 or a physician’s office that sells prescriptions under the table to anyone with
cash.21
Regardless of the positive effects with the enactment of H.B. 93, Ohio needs to
take more action to prevent prescription abuse. Ohio was at the cusp of tackling the
prescription abuse epidemic, but fell short of the results it was capable of attaining.22
Specifically, H.B. 93 falls short because it does not focus on prevention.23 Instead,
H.B. 93 only gives OARRS the capability to identify clinics that supply patients with
unnecessary quantities of medication.24 While this prevents some prescription abuse,
it does not go far enough. For instance, most physicians may use Ohio’s
Prescription Monitoring Program (PMP), also known as OARRS, but only few
physicians are required to do so.25 However, used to its full potential, OARRS can
provide physicians with more information to identify drug-seeking behaviors of
patients.26
Also, H.B. 93 does not address other issues that facilitate drug abuse.27 One
reason why prescriptions are so easily abused is because there are so many of them
in the house.28 Another reason is that patients are not effectively held accountable

18

See Ohio Sheriffs' Group Seeks Better Drug Monitoring, supra note 14.

19

See H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at
http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93.
20

Russ Zimmer, Ohio Law Nixes Pill Mills, BUCYRUS TELEGRAPH F. (May 21, 2011),
http://www.bucyrustelegraphforum.com/article/20110522/NEWS01/305220007/Ohio-lawnixes-pill-mills.
21
What is a Pill Mill?, THE OFFICIAL BLOG SITE OF THE BAY AREA COUNCIL ON DRUGS &
ALCOHOL, http://www.bacodablogs.com/2011/01/what-is-pill-mill.html (last visited Oct. 28,
2012).
22
See OHIO STATE BOARD OF PHARMACY, OHIO’S DANGEROUS DRUG DATABASE PAST,
PRESENT, AND FUTURE: HOUSE BILL 93 REPORT (2011) available at
https://www.ohiopmp.gov/Portal/Search.aspx?searchText=past%2c+present%2c+future.
23
See infra Part III.B.2 (discussing the reactive nature of Ohio’s current prescription
legislation).
24

See Doctor Shopping Chronic Pain Medication Addiction, supra note 16 (“[drug
databases] allow physicians and pharmacists to cross-check prescriptions with each other and
identify individuals who may be doctor shopping”).
25
See infra Part II.F (discussing the current state of Ohio’s laws vis-à-vis prescription
reporting).
26

See OHIO STATE BOARD OF PHARMACY, supra note 22.

27

See H.B. 93, supra note 19.

28

See infra Part II.C. Part II.C discusses various sources of prescription drugs that are
abused. Although this Note identifies three unique sources (pill mills, doctor shopping, and
the home), these sources are interrelated because prescriptions obtained either from doctor
shopping or from a pill mill invariably end up in homes, where other persons can access them.
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for doctor shopping.29 Thus, Ohio should mandate OARRS reporting and monitoring
by all prescribers, promote OARRS interconnectivity with other states, mandate
prescription return programs, and create stronger anti-doctor shopping statutes to
effectively curb prescription abuse.
Prescription abuse in Ohio continues to be a serious and complex issue that
should be addressed. Accordingly, Part II of this Note examines the background of
prescription drug abuse generally. It identifies the dangers of prescription drug
abuse, the cost drug abuse places on society, some reasons for prescription drug
abuse, sources of prescription drugs, and discusses the current state and federal laws
regarding prescription drug abuse and prescription reporting. Part III discusses the
positive and negative aspects of H.B. 93 and Medical Rule 4731-11-11 and then
offers proposals to more effectively prevent prescription drug abuse. Part IV
discusses various criticisms of the current OARRS system and demonstrates why
these concerns are either unfounded or do not outweigh the benefits of having such a
system.
II. BACKGROUND
Prescription drug abuse is a complicated topic with many facets. To help
understand the topic, it is necessary to discuss the dangers, costs, causes, and sources
of prescription abuse, and to look at the relevant federal and Ohio statutes that
pertain to prescription abuse. Thus, Part A identifies the dangers of abusing opioids,
tranquilizers, and stimulants—three of the most commonly abused classes of
prescriptions. Part B discusses the costs that prescription abuse places on society.
Part C proffers various reasons for prescription drug abuse. Part D identifies pill
mills, doctor shopping, and the home as major sources of prescription drugs. A brief
description of the Controlled Substances Act, which regulates drugs at the federal
level, can be found in Part E. Finally, Part F provides an overview of the statutory
scheme surrounding prescription drug abuse in Ohio.
A. Dangers of Prescription Drug Abuse
The dangers of prescription drug abuse are well documented. Prescription drug
abuse is “the intentional use of a medication without a prescription; in a way other
than as prescribed; or for the experience or feeling it causes.”30 The most commonly
abused medications are pain relievers,31 tranquilizers,32 and stimulants.33 As will be

29
See infra Part III.B.1 (discussing in part the shortcomings of Ohio’s anti-doctor shopper
statute).
30

NATIONAL INSTITUTE ON DRUG ABUSE, PRESCRIPTION DRUG ABUSE (December, 2011),
available at http://www.drugabuse.gov/sites/default/files/prescription_1.pdf.
31

“Opioids are commonly prescribed [as pain relievers] because of their effective
analgesic, or pain-relieving, properties. Medications that fall within this class-referred to as
prescription narcotics-include morphine (e.g., Kadian, Avinza), codeine, oxycodone (e.g.,
Oxycontin, Percodan, Percocet), and related drugs.” NATIONAL INSTITUTE ON DRUG ABUSE,
PRESCRIPTION DRUGS ABUSE AND ADDICTION (2001), available at http://www.chce.research
.va.gov/docs/pdfs/RRPrescription.pdf.
32

NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30.

33

NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30.
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discussed in more detail, the abuse of opioids, tranquilizers, and stimulants can have
devastating effects on the human body.
1. Opioids
“The term opiates refers to naturally occurring alkaloids, such as morphine,
codeine, and thebaine . . . that are derived from the opium poppy plant.”34 Abusing
opioids can be very harmful to the body.35 Opioid chemicals bind to the opioid
receptors in the central nervous system36 and provide an analgesic effect because
they decrease and alter the sensation of pain.37 Opioid abuse may lead to
drowsiness, and may dangerously decrease the rate of breathing.38 Furthermore, “if
combined with other medications that cause drowsiness or with alcohol, heart rate
and respiration can slow down dangerously.”39 In addition, a person’s prolonged use
of opioids can dull the effects of the drug because the body becomes tolerant of the
drugs’ effects.40 Consequently, a person taking the drugs may increase their
dosage.41 Finally, opioid addiction is most common in those who abuse these drugs
recreationally, and the unpleasant withdrawal effects tend to reinforce the
addiction.42 Ironically, the Ancient Sumerians referred to the opium plant as “hu gil”
or “plant of joy,”43 perhaps alluding to its propensity for abuse.44
34
Susan Y. Kim-Katz & Ilene B. Anderson, Prescription Opiate/Opioid Drug Abuse: A
New Epidemic, THE AM. C. OF CHEST PHYSICIANS (Jan. 1, 2011), available at
http://www.chestnet.org/accp/pccsu/prescription-opiateopioid-drug-abuse-newepidemic?page=0,3. See also Transforming Opium Poppies into Heroin, PBS,
http://www.pbs.org/wgbh/pages/frontline/shows/heroin/transform/ (last visited Oct. 28, 2012).
35

See Kim-Katz & Anderson, supra note 34.

36

How Do Opioids Work in the Brain?, THE NATIONAL ALLIANCE OF ADVOCATES FOR
BUPRENORPHINE TREATMENT, http://www.naabt.org/faq_answers.cfm?ID=6 (last visited Oct.
28, 2012).
37

Steve Richeimer & Susan Spinasanta, Drugs Used to Treat Pain: Opioids – Narcotics,
SPINEUNIVERSE.COM, http://www.spineuniverse.com/treatments/medication/drugs-used-treatpain-opioids-narcotics (last updated on Feb. 1, 2010).
38
NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30; see also Opioid Side Effects,
NEWS MEDICAL, http://www.news-medical.net/health/Opioid-Side-Effects.aspx (last visited
Oct. 28, 2012) (“Although [respiratory depression] is the most serious adverse reaction
associated with opioid use[, respiratory depression] usually is seen with the use of a single,
intravenous dose in an opioid-naive patient.” Thus, the dangers of respiratory depression are
most prevalent in those who take prescriptions on a recreational basis.).
39
What is Prescription Drug Abuse?, NATIONAL INSTITUTE ON DRUG ABUSE (AUG. 7,
2012), http://www.nida.nih.gov/researchreports/prescription/prescription2.html.
40

See generally Kathleen M. Foley, Changing Concepts of Tolerance to Opioids: What
the Cancer Patient Has Taught Us, CURRENT AND EMERGING ISSUES IN CANCER PAIN:
RESEARCH AND PRACTICE (1993), available at http://painresearch.utah.edu/cancerpain/ch20.
html (evaluating the effects of drug tolerance in cancer patients).
41

Risks of Opiate Abuse, THE WAISMANN METHOD, http://www.opiates.com/opiateabuse.html (last visited Oct. 28, 2012).
42
43

See Opioid Side Effects, supra note 38.

Charles J. Fox III et al., Opioids: Pharmacokinetics and Pharmacodynamics, in 91
ESSENTIALS OF PAIN MANAGEMENT (Nalini Vadivelu et al. eds., 2011); see also Kim-Katz &
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Opioids also have indirect effects on the health of patients with a history of
prescription drug abuse.45 For example, healthcare “providers tend to undertreat pain
in this population due to biases, misconceptions, and systems issues.”46 Thus, when
patients with a substance abuse history are actually in pain and need medicine,
physicians fear that the patient is “crying wolf” in an attempt to secure more
medication.47 This undertreatment results in “increased length of stay [at a hospital],
frequent readmissions, and increased outpatient and emergency visits.”48
Opioid abuse is so pervasive that it impacted nearly an entire generation of
people living in southern Ohio.49 The most popular drug abused in Scioto County,
Ohio, is an opioid by the name of Oxycontin.50 “Nearly 1 in 10 babies born last year
in this Appalachian county tested positive for drugs.”51 The situation in Scioto
County has been compared to the drug abuse epidemics of the 1970’s and 1980’s: “a
generation of young people…were raised by their grandparents because their parents
were addicts, and now they are addicts themselves.”52 The addiction to opioids
creates such desperation that in some instances people will kill and commit other
crimes to get access to Oxycontin.53 For instance, a local elderly man had access to
Oxycontin prescriptions, and a burglar broke into his house to search for them.54
Anderson, supra note 34 (“The Sumerians first cultivated the opium poppy around 3400 BC
and referred to it as Hul Gil, or the ‘joy plant.’”).
44

See Transforming Opium Poppies into Heroin, supra note 34.

45

Marian S. Grant et al., Acute Pain Management in Hospitalized Patients with Current
Opioid Abuse, MEDSCAPE NEWS (June 6, 2007), http://www.medscape.com/viewarticle
/557043_3.
46

Id.; see also Pain Management and Addiction, TREATMENT-CENTERS.NET (July 25,
2012), http://www.treatment-centers.net/pain-management-and-addiction.html.
47

Pain Management and Addiction, supra note 46.

48

See Grant, supra note 45.

49

See generally Tavernise, supra note 2 (describing Portsmouth’s plight with prescription
abuse).
50

Id.

51

Id.

52

Id.; see also Grace Wyler, Obama, GOP Govs., Want More Spending To Fight
OxyContin Epidemic, BUS. INSIDER, (Apr. 20, 2011), http://articles.businessinsider.com/201104-20/politics/30002690_1_prescription-drug-abuse-overdoses-oxycontin-first (“Prescription
drug abuse has long been a scourge across Appalachia, claiming more lives than the '80s crack
epidemic and the '70s heroin epidemic combined, [as reported by the Tavernise article, supra
note 2].”).
53

See Frank Lewis, Two Found Fatally Shot in Lucasville, PORTSMOUTH DAILY TIMES,
(Jan. 11, 2010, 12:00 AM), http://www.portsmouthdailytimes.com/pages/full_story/push?
articleTwo+Found+Fatally+Shot+In+Lucasville%20&id=5510425&instance=secondary_new
s_left_column; see also Julian Borger, Hillbilly Heroin: The Painkiller Abuse Wrecking Lives
in West Virginia, THE GUARDIAN (June 24, 2001), http://www.guardian.co.uk/world/2001
/jun/25/usa.julianborger (“The OxyContin epidemic has meanwhile generated an exponential
rise in the crime rate, as addicts become ever more desperate to finance their craving.”).
54

See Tavernise, supra note 2.

110

JOURNAL OF LAW AND HEALTH

[Vol. 26:103

This burglar then killed the man and the woman he was living with, while the
woman’s young daughter watched.55
2. Tranquilizers
Another drug that is readily available and can be dangerous when abused is
tranquilizers.56 Tranquilizers are commonly prescribed as anti-anxiety medications
and sleep aids, and are part of the group of drugs known as depressants.57
Tranquilizers include Xanax, Valium, and Ativan.58 Tranquilizers operate by
inducing a feeling of calm or well-being.59 Also, combining an opioid with a
depressant, such as a tranquilizer, can have dangerous health effects; for example, a
user’s heart rate and breathing may decrease to a dangerous level.60 Combining
tranquilizers with alcohol or opioids will similarly decrease the taker’s heart rate to a
dangerous level.61 But unlike opioids or tranquilizers, alcohol does not require a
prescription and is commonly found in many households.
One of the most-publicized instances of overdose of tranquilizers was the recent
case of Michael Jackson.62 A lethal cocktail of Propofol, Lorazepam, and
Midazolam caused Michael Jackson’s death.63 On June 25, 2009, the artist who gave
us such masterpieces as “Thriller,” “Billy Jean,” and “The Man in the Mirror” went
into cardiac arrest in his mansion in Los Angeles, California.64 Subsequent attempts

55

Id.; see also Lewis, supra note 53.

56
Tranquilizers, INSTITUTE FOR SUBSTANCE ABUSE TREATMENT EVALUATION, http://www.i
sate.memphis.edu/tranquilizers.html (last visited Oct. 28, 2012).
57

Id.

58

Id.

59

Id.

60

See supra Part II.A.1 (describing harmful side effects on the body when opioids are
combined with tranquilizers).
61

See supra Part II.A.1.

62

See Katherine Harmon, What is Propofol—and How Could It Have Killed Michael
Jackson?, SCI. AM., (Oct. 3, 2011), http://www.scientificamerican.com/article.cfm?id=
propofol-michael-jackson-doctor.
63
See id. (explaining that Propofol is a hypnotic that is used to induce general anesthesia);
Lorazepam, NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, http://www.ncbi.nlm.
nih.gov/pubmedhealth/PMH0000560/ (last revised Oct. 1, 2010) (Lorazepam is a
benzodiazepine used to treat anxiety); Midazolam, NATIONAL CENTER FOR BIOTECHNOLOGY
INFORMATION, http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000482/ (last revised Nov.
1, 2010) (“Midazolam is given to children before medical procedures or before anesthesia for
surgery to cause drowsiness, relieve anxiety, and prevent any memory of the event.”);
Benjamin C. Wedro, Michael Jackson’s Death: Propofol (Diprivan) FAQ, MEDICINE.NET,
http://www.medicinenet.com/script/main/art.asp?articlekey=113188 (last editorial review
Nov. 8, 2011) (discussing that Michael Jackson’s death was caused by Propofol, Lorazepam,
and Midazolam taken together).
64

Shulamit Shvartsman, What Caused Michael Jackson’s Sudden Death?, LAWYERS.COM,
http://product-liability.lawyers.com/Product-Liability/What-Caused-Michael-JacksonsSudden-Death.html (last visited Aug. 29, 2012); Michael Jackson’s Life Cut Shockingly Short,
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to resuscitate him by his personal physician, paramedics, and the personnel at a
hospital emergency room were unsuccessful.65 Over an hour after going into cardiac
arrest, Michael Jackson was pronounced dead at Ronald Reagan University of
California at Los Angeles Medical Center.66 The medications that caused Michael
Jackson’s death were prescribed and administered to him by his personal physician.67
Although tranquilizers have a common use—such as treating insomnia—they can be
dangerous, and thus, their abuse needs to be controlled.68
3. Stimulants
Similar to tranquilizers, stimulants have a common household use, and are also
easily abused.69 Common prescription stimulants include Adderall, Ritalin, and
Concerta.70 These drugs are typically used to treat Attention Deficit Hyperactivity
Disorder (ADHD).71 But, ADHD drugs are a Schedule II narcotic, and thus, have a
“limited medical purpose, with a high potential for abuse.”72 Because these drugs
facilitate a better ability to concentrate, college students frequently abuse them in an
effort to keep up with a heavy class load.73 Students consider the effects of these
drugs so beneficial that, according to a 2002 University of Wisconsin study, “20
percent of college students have used Adderall or Ritalin without a prescription.”74
Students who use these drugs often say that the drugs helped them finish their work
and remain focused.75
Despite the perceived benefits of stimulant abuse, these drugs have severe
medical consequences. Side effects include dry mouth, lack of hunger, insomnia,

MSNBC, http://today.msnbc.msn.com/id/31552029/ns/today-entertainment/t/michaeljacksons-life-cut-shockingly-short/#.TrXN63JRQW0 (last visited Oct. 28, 2012).
65

Shvartsman, supra note 64.

66

Michael Jackson’s Life Cut Shockingly Short, supra note 64.

67

See Wedro, supra note 63.

68

See Tranquilizers, supra note 56.

69

See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30.

70

See generally Peter R. Breggin, Adderall Ritalin Concerta Side Effects in Adults and
Child Medication, NATIVEREMEDIES, http://www.nativeremedies.com/articles/concerta-ritalinadderal-side-effects.shtml (last visited Oct 28, 2012) (describing use and effects of commonly
prescribed ADHD stimulants).
71

Id.

72
See generally 21 U.S.C.S. § 812 (LexisNexis 2011) (describing the different schedules
of drugs); see also Controlled Substances – Alphabetical Order, supra note 9 (depicting a list
of various controlled substances, of which Amphetamine (Adderall) and Methylphenidate
(Ritalin) are listed as Schedule II drugs).
73

Kelsie Smith, Dangers of Stimulant Abuse, THE U. DAILY KANSAN, (Feb. 2, 2006),
http://kansan.com/archives/2006/02/02/dangers-of-stimulant-abuse/.
74

Id.

75

Id.
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nausea, and addiction.76 Death can result in some cases when primary use of the
drug causes “exploded blood vessels in the brain, heart attack, or dangerously
elevated body temperature.”77 Further, because these drugs cause insomnia, a patient
may begin abusing depressants to help themselves sleep.78 Consequently, uppers in
the morning, and downers at night.79 Interestingly, many students who take Adderall
may not realize that the chemical name of this drug is “amphetamine.”80 Further,
“[o]ne of the easiest ways to make methamphetamine is from amphetamine.”81
Thus, an increase in the amount of Adderall available on the street may lead to
increased quantities of methamphetamine on the street.82 Stimulants, similar to
tranquilizers, have a common medical use, but they are still dangerous.83 Thus, their
use needs to be controlled to prevent abuse.
B. Costs of Prescription Abuse
In addition to the dangerous health effects of prescription abuse, drug abuse also
has a high cost on society. Firstly, accidental drug overdose is the leading cause of
accidental deaths for Ohioans since 2007.84 Furthermore, these “[f]atal and non-fatal
poisonings [with prescription drugs] cost Ohioans $3.6 billion annually.”85
Exacerbating the costs of prescription abuse, the “Ohio Substance Abuse Monitoring
(OSAM) Network report[ed] a move from prescription painkillers to heroin among
opiate abusers” and found that that “heroin is highly available in all regions of the
state.”86 Heroin abuse places additional costs on citizens. These costs are initially
76
See Side Effects of Prescription Stimulants, STEADYHEALTH.COM, http://www.
steadyhealth.com/articles/Side_effects_of_prescription_stimulants_a674.html (last visited
Oct. 28, 2012); What are Amphetamines?, INFO DRUG REHAB , http://www.info-drugrehab.com/amphetamines.html (last visited Oct. 28, 2012).
77

See What are Amphetamines?, supra note 76.

78

See InfoFacts: Prescription and Over-the-Counter Medications, NATIONAL INSTITUTE
http://www.drugabuse.gov/publications/drugfacts/prescription-over-countermedications (last revised May, 2012).
ON DRUG ABUSE,

79
“‘Downers’ in the evening and ‘uppers’ in the morning may be regarded as part of a
popular entertainer’s professional equipment, as well as an occupational health hazard for the
profession.” Thomas Szasz, Who Killed Michael Jackson?, THE FREEMAN (Mar., 2012),
http://www.thefreemanonline.org/columns/the-therapeutic-state/who-killed-michael-jackson/.
80

See Breggin, supra note 70.

81

Methamphetamine Frequently Asked Questions, THE VAULTS OF EROWID, http://www.
erowid.org/chemicals/meth/meth_faq.shtml (last updated Jan., 2005).
82

See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30 (“Between 1991 and 2010,
prescriptions for stimulants [such as Adderall] increased from 5 million to 45 million.” Thus,
if there was a nine-fold increase in the amount of prescriptions written for stimulants in the
last 20 years, it can be inferred that there is a nine-fold increase in the amount of stimulants
that can be available to make methamphetamine, as compared to 20 years ago.).
83

See generally supra Part II.A.2 (describing the dangers of tranquilizer abuse).

84

STATE MEDICAL BOARD OF OHIO, supra note 2.

85

Id.

86

Ohio’s Opiate Epidemic, OHIO DEPARTMENT OF ALCOHOL AND DRUG ADDICTION
SERVICES (July, 2011),
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borne by law enforcement and the criminal justice system, which must combat
illegal heroin abuse, and these costs then forwarded to the taxpayers. 87 Put bluntly,
because Ohioans cannot afford to tolerate prescription drug abuse, Ohio needs to
step up to the plate and better combat prescription abuse.
C. Reasons for Prescription Drug Abuse
Despite the inherent danger and costs of abuse, there are many reasons why
people abuse prescription drugs. Some people assume that a drug is safe because it
is available through a prescription.88 This is not necessarily true.89 Some people
abuse these drugs because they are readily available.90 In fact, “[b]etween 1991 and
2010, prescriptions for stimulants increased from five million to forty-five million, a
nine-fold increase, and opioid analgesics increased from about thirty million to onehundred-eighty million, a six-fold increase.”91 Other people abuse prescription drugs
for their performance-enhancing capabilities.92 Still others abuse these drugs to feel
the effect of the drug, to get high, or to ameliorate stress.93 For instance, injecting or
snorting opioids elicits “a warm, floating feeling. Some say they feel pleasantly
numb.”94 Given the diverse reasons for prescription drug abuse, a solution that can
address each of these reasons is needed.
D. Sources of Prescription Drugs Used for Abuse
Despite the inherent costs and dangers of prescription drug abuse, these drugs are
readily available. Prescription drugs are readily available through pill mills, doctor
shopping, and can even be found in the home.95 As shown below, the ease through
which controlled drugs can be accessed needs to be addressed.
1. Pill Mills
Pill mills are only one piece to the puzzle of prescription drug abuse. A pill mill
is a “doctor, clinic or pharmacy that is prescribing or dispensing powerful

http://www.odadas.state.oh.us/public/OpenFile.aspx?DocumentID=e934f58b-74cf-4e1c-b2a052eca5f6c271, see also infra Part II.D.2 (further detailing the costs and dangers that
prescription drug abuse and heroin abuse places on the individual as well as society).
87

Id.

88

See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30.

89

See generally supra Part II.A (describing the dangers of prescription drug abuse).

90

See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30.

91

See id. These increases demonstrate that the amount of drugs available to the general
public has increased dramatically over the last two decades. Id.
92

See generally supra Part II.A.3 (describing the phenomenon of college students abusing
stimulants, such as Adderall or Ritalin to cope with a difficult class load).
93

See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30.

94

Rachel Dissell, Overdose Deaths Climb as Painkillers, Heroin Pour into Ohio Market,
THE PLAIN DEALER (Feb. 20, 2011, 6:00 AM), http://blog.cleveland.com/metro/2011/02/
overdose_deaths_climb_as_paink.html.
95

See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30.
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[prescription] narcotics inappropriately or for non-medical reasons.”96 Pill mills
generally operate as cash-only pain management clinics.97 Pill mills also tend to
open and close down quickly to evade law enforcement.98 They are characterized by
long waits in line, and sometimes an absence of a single consultation with a
physician.99 Patients are frequently invited to “pick their poison” by indicating
which medication they want, with no questions asked by the physician.100 Physicians
at these clinics rarely, if ever, explore alternative pain management techniques, and
treat with pain pills only.101 The patient is then given a prescription for the drug of
their choice.102 If the patient does not receive the drug immediately in the office, they
are directed to a “preferred” pharmacy that will fill the prescription without issue.103
The danger of pill mills goes far beyond harm to the health of an individual
patient. For example, if a patient visits multiple pill mills,104 they can amass a large
quantity of drugs.105 Patients can then consume drugs from this collection as they
wish or sell them on the street, which presents a hazard to the community.106
Another identified harm, beyond the harm to the individual patient, occurs when
patients fill their prescription in another state. In such cases the state where the pill
mill is located will have difficulty identifying prescription drug abuse.107

96
Pia Malbran, What’s a Pill Mill?, CBS NEWS (May 31, 2007 6:01 PM),
http://www.cbsnews.com/8301-501263_162-2872835-501263.html.
97

What is a Pill Mill?, supra note 21. Since pill mills operate as a cash-only business,
insurance companies cannot monitor patient drug use. Id. Insurance companies will often
monitor the drugs a patient receives, and refuse to pay for a drug if the patient recently had
this medication filled, and still should have some medication left. Thus, it is difficult for the
patient to amass a large supply of drugs. See Fighting the Scourge of Pill Mills, CBS NEWS
(Oct. 16, 2011 9:35 AM), http://www.cbsnews.com/stories/2011/10/16/sunday/main
20121033.shtml (characterizing pill mills as a cash-only operation).
98

See Malbran, supra note 96.

99

What is a Pill Mill?, supra note 21.

100

Id.; Malbran, supra note 96.

101

What is a Pill Mill?, supra note 21; Malbran, supra note 96.

102

See Malbran, supra note 96 (identifying one of the signs of a pill mill as the patient
picking their own medication, no questions asked).
103

What is a Pill Mill?, supra note 21; Malbran, supra note 96.

104

See infra Part II.D.2 (discussing doctor shopping as a source for medications to abuse).

105

In one instance, a patient in Georgia obtained a five-year supply of Oxycontin in one
year by visiting dozens of pharmacies and almost sixty different doctors, and these drugs were
paid for by taxpayers because the patient’s medications were covered by Medicare. See Robert
Lowes, ‘Doctor-Shoppers’ Get Pain Meds at Medicare’s Expense, MEDSCAPE NEWS TODAY
(October 26, 2011), http://www.medscape.com/viewarticle/752340.
106

See infra Part II.D.ii (discussing the dangers inherent in drugs sold on the street).

107
See generally infra Part III.C.2 (discussing the interconnectivity of the OARRS system
and its ability to interface with the patient prescription databases of other states).
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2. Doctor Shopping
Another source of collecting medications for abuse is the process known as
“doctor shopping.”108 Doctor shopping is the process of receiving treatment from
multiple physicians concurrently.109 These physicians often do not know that the
patient is receiving treatment from other physicians.110 Doctor shoppers will often
visit multiple physicians until they receive a prescription for their “preferred”
drug.111 Doctor shoppers will visit physicians that they do not know to further mask
their true intent.112 This process results in overmedicating patients; for example, a
patient receiving Oxycontin from one physician may receive the same drug from
another physician.113
The danger of doctor shopping is exacerbated by the existence of pill mills.114
The patient who “shopped” for the medication at multiple pill mills can either use
the drugs from the resulting horde of medications, or sell them for a profit.115
Oxycontin can sell for approximately $0.50 to $1/mg on the street.116 Thus, a single
40mg pill of Oxycontin can sell for $20 to $40 illicitly. To make matters worse, the
price of a 40mg pill of Oxycontin purchased legally from a pharmacy is $4/pill.117
Therefore, given a prescription for 90 pills of Oxycontin (1 pill, three times a day), a
patient will pay $360 for the prescription, assuming the patient’s insurance is not
involved.118 This same prescription can be sold on the street for $1,800 to $3,600.

108

See Lowes, supra note 105.

109

David L. Robinson, Note & Comment, Bridging the Gaps: Improved Legislation to
Prohibit the Abuse of Prescription Drugs in Virginia, 9 Appalachian J. L. 281, 289 (2010).
110

Id.

111

Id.

112

See Madison Park, How Physicians Try to Prevent ‘Doctor Shopping’, CNN HEALTH
(Apr. 7, 2010), http://articles.cnn.com/20100407/health/doctor.shopping.haim_1_prescriptiondrugs-xanax-doctor-shopping?_s=PM:HEALTH.
113

See id. Doctor shoppers will try various ways to obtain more medication. In addition to
visiting multiple doctors, shoppers will “call during weekends [presumably when the doctor
does not have his or her record on hand] or ask for prescription refills using excuses such as
having dropped the pills in toilets or getting pills wet on a camping trip.” Id. See also Sara
Jane Tribble, Ohio Lawmakers Want to Mandate Prescription Monitoring by Doctors, THE
PLAIN DEALER, (Jan. 20, 2010), http://www.cleveland.com/healthfit/index.ssf/2010/01
/lawmakers_want_to_mandate_pres.html (“If doctors were required to check the database,
they would spot patients who were pill shopping, going to multiple pain clinics and
emergency rooms to obtain prescriptions or samples.”).
114

Doctor shoppers can quickly amass a large quantity of drugs. This quantity would
likely increase where the patient visits a pill mill that readily hands out medications with no
qualms. See Lowes, supra note 105.
115

Id.

116

OxyContin Diversion and Abuse, THE NATIONAL DRUG INTELLIGENCE CENTER (Jan.
2001), http://www.justice.gov/archive/ndic/pubs/651/abuse.htm.
117

Id.
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Combine this absurd profit margin with a high unemployment rate,119 and it is easy
to see why patients could be tempted to “shop” for Oxycontin to supplement their
income.120
These high costs have other negative impacts. For example, those who can no
longer afford the street price of Oxycontin may be pushed to use heroin,121 which is
available in many parts of the country.122 Both heroin and Oxycontin are opioid
derivatives123 and therefore, they provide similar effects.124 Currently, the cost of
heroin is around $172/gram, or $0.17/mg.125 Compare this price to the street price of
Oxycontin at a minimum of $20 for a 40mg pill,126 and an abuser’s decision to
switch from Oxycontin to heroin makes financial sense, if nothing else.127
Heroin abuse is not a problem limited to the inner-city.128 Deaths related to this
drug are increasing in Ohio’s affluent suburbs, such as Independence, where four
persons overdosed on heroin in less than eight weeks.129 Switching from Oxycontin
to heroin can be more dangerous; heroin may be laced with other chemicals because
it is unregulated by the government.130 In addition, an addict who abuses heroin
places additional costs on law enforcement agencies, and ultimately the taxpayer.131
Ohio cannot afford to pay these costs. Thus, combating Oxycontin abuse, whether
118

If the patient’s insurance company is kept out of the loop with the medications a patient
receives, then it will be easier for patients to get multiple prescriptions of the same
medication. See What is a Pill Mill?, supra note 21.
119

Local Area Unemployment Statistics, supra note 10.

120

See Borger, supra note 53 (“[Law enforcement officers are] trying to do [their] best to
combat the dealers, who are often families on welfare trying to earn extra money.”).
121

OxyContin Diversion and Abuse, supra note 116.

122

Ohio’s Opiate Epidemic: User Profiles, supra note 86.

123

NIDA InfoFacts: Heroin, NATIONAL INSTITUTE ON DRUG ABUSE, http://www.nida.nih.
gov/infofacts/heroin.html (last updated Mar. 2010).
124

See Dissell, supra note 94.

125

OFFICE ON DRUGS AND CRIME, UNITED NATIONS, 2008 WORLD DRUG REPORT 257
(2008), available at http://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_
web.pdf.
126
Oxycontin on the street can sell for approximately $0.50 to $1/mg. Thus, a single 40mg
pill of Oxycontin can sell for $20 to $40 on the street. See OxyContin Diversion and Abuse,
supra note 116.
127

See Dissell, supra note 94.

128

See Dissell, supra note 94.

129

Tracy Carloss, Independence Bands Together to Fight Heroin After Four Overdoses in
Eight Weeks, WEWS NEWS CHANNEL 5 (Jun. 16, 2006), http://www.newsnet5.com/dpp/news/
local_news/oh_cuyahoga/independence-bans-together-to-fight-heroin-after-4-overdoses-in-8weeks.
130
See Christian Nordqvist, Fentanyl-laced Heroin Kills Hundreds Of Addicts in USA,
MED. NEWS TODAY (June 16, 2006), http://www.medicalnewstoday.com/articles/45391.php.
131
See generally supra Part II.B (describing the costs that prescription abuse places on
society).
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due to doctor shopping or other causes, will have the positive side effect of
preventing heroin abuse.132
3. The Home
To find another source of prescription medications, one need only look in the
mirror, or rather, behind the mirror. As mentioned above, prescriptions for
controlled substances have increased dramatically in the last twenty years.133 This
leads to an increased likelihood of unused prescriptions in the medicine cabinet.134
These medications may be enticing to teenagers for “pharming,” who will in turn
share the medications with friends who “pharmed” their own medicine cabinets. 135
These medications are placed in a bowl called “trailmix,” which everyone shares at
an event called a “pharm party.”136 The teens take pills from the “trailmix”
randomly until they reach a sufficient high.137 But, not all pill combinations will
make the taker feel high. Accordingly, teens tend to consume more pills, thereby
increasing the risk that they may unwittingly overdose on the “trailmix”.138
Pharm parties and similar problems are not exclusive to teenagers. On March 2,
2012, a first-grade student from Cleveland, Ohio brought a bottle of anti-depressant
medications to school and passed them out.139 While there was no evidence that the
child had bad intentions—as he may have thought that the medications were
candy—eight students were still taken to the hospital.140 Thankfully, none of the
children developed life-threatening complications.141 But, this story should serve as
132

See Dissell, supra note 94.

133

NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30.

134

Cf. Stan Donaldson, Prescription Drug Collection Nets More than 8,700 Pounds in
Cleveland Area, THE PLAIN DEALER (Nov. 3, 2011 5:45 AM), http://blog.cleveland.com/metro
/2011/11/prescription_drug_collection_n.html. While this article does not establish a causal
relationship between number of prescriptions written and the amount of unused prescriptions
in the home, the fact that over four tons of medications were collected at a local drug takeback program supports the inference that there is a large amount of unused medications in
peoples’ homes.
135

Donna Leinwand, Prescription Drugs Find Place in Teen Culture, USA TODAY (June
13, 2006 7:40 PM), http://www.usatoday.com/news/health/2006-06-12-teens-pharmdrugs_x.htm. See also Kim-Katz & Anderson, supra note 34 (“Disturbingly, 41% of [teens]
surveyed agreed that ‘using prescription drugs without a prescription is much safer to use than
illegal drugs.’ This belief likely fuels the latest trend in drug abuse called “pharming,” the
practice of adolescents raiding medicine cabinets in search of finding drugs for abuse.”)
136

See Leinwand, supra note 135.

137

Monica Kim Sham, Note, Down on the Pharm: The Juvenile Prescription Drug Abuse
Epidemic and the Necessity of Holding Parents Criminally Liable for Making Drugs
Accessible in their Homes, 27 J. CONTEMP. HEALTH L. & POL'Y 426, 436-37 (2011).
138

Id.

139

Kevin Freeman, Parents Shocked Over Elementary Overdose, FOX 8 CLEVELAND,
(March 2, 2012, 10:35 PM), http://fox8.com/2012/03/02/elementary-school-students-rushedto-hospital-after-overdose/.
140

Id.

141

Id.
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a warning of the dangers of prescription medications, and the ease to which they can
be accessed in the home. It would be difficult to fashion a law that would prevent a
situation like this. For this reason, primary responsibility lies with the parents to
educate their children so that they understand that prescription medications are not
candy, and can be dangerous when taken.
As shown above, dangerous prescription medications are readily available to the
public in many forms. Specifically, controlled prescription drugs can be procured
through pill mills, doctor shopping or in the home.142 Once the drugs are obtained, it
is easy and even profitable to sell them on the street.143 Moreover, prescription drug
abuse is dangerous to the health of an individual144 and places high costs on
society.145 Although these drugs are dangerous and can be accessed easily, they still
serve an important role in healthcare and it is necessary to find a solution capable of
balancing competing illicit and legitimate medical interests.
E. Current State of Federal Law: Controlled Substances Act
In 1970, President Richard Nixon signed into law the Controlled Substances Act
(“CSA”).146 The CSA is a federal act that regulates the manufacture, possession, and
distribution of certain medications.147 Among other things, the law creates five
classifications (commonly known as “schedules”) to group various controlled
substances.148 The drugs are placed in schedules based on their potential for abuse
and whether they have any currently accepted medical use.149 Schedule I contains
drugs that have the highest potential for abuse and no accepted medical use;
examples include marijuana and heroin.150 Schedule II drugs have a high potential
for abuse and severely limited medical purpose151—they include Adderall
(amphetamine), Morphine, and Oxycontin (Oxycodone).152 Currently, physicians
142

See generally supra Part II (discussing access to controlled prescription drugs).

143

See generally supra Part II.D.2 (discussing the financial incentives to sell prescription
drugs on the street).
144

See generally supra Part II.A (discussing the health effects of abusing medications).

145

See generally supra Part II.B (discussing the costs prescription drug abuse places on
society).
146

See Thirty Years of America’s Drug War, PBS, http://www.pbs.org/wgbh/pages/
frontline/shows/drugs/cron/ (last visited Oct. 28, 2012) (While the source does not directly
state that President Nixon signed the bill into law, it can be inferred that he did because the
law was enacted in 1970, during Richard Nixon’s presidency.).
147
See 21 U.S.C.S. § 801 (LexisNexis 2011) (discussing congressional findings regarding
the possession, manufacture, and distribution of controlled substances).
148

21 U.S.C.S. § 802(6) (LexisNexis 2011).

149

21 U.S.C.S. § 812 (LexisNexis 2011).

150

21 U.S.C.S. § 812(c) (LexisNexis 2011).

151

21 U.S.C.S. § 812 (LexisNexis 2011).

152

21 U.S.C.S. § 812(c) (LexisNexis 2011); see Drugs and Medications – Adderall Oral,
WEBMD, http://www.webmd.com/drugs/drug-63163Adderall+Oral.aspx?drugid=63163
&drugname=Adderall+Oral (last visited Oct. 28, 2012) (the generic name for Adderall is
amphetamine); see Drugs and Medications – OxyContin Oral, WEBMD, http://www
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may only write prescriptions for drugs in Schedules II through V.153 Because the
medical profession is highly regulated by the government, the Ohio legislature has
the ability to enact a solution that more effectively curbs prescription drug abuse,
such as the Oxycontin epidemic in Southern Ohio.154
F. Current State of Ohio Law vis-à-vis Prescription Reporting
In 2006, the Ohio Pharmacy Board created the Ohio Automated Rx Reporting
System (“OARRS”) in part to identify drug-seeking behaviors of patients.155
OARRS is an online patient database that aggregates patient data into reports that
can be accessed by physicians, pharmacists, and law enforcement.156 Similar patient
databases are used in many states.157 The reports from these databases provide
healthcare professionals and law enforcement agencies with valuable information
such as a patient’s prescription history and physicians’ prescribing trends.158 The
.webmd.com/drugs/drug-2798OxyContin+Oral.aspx?drugid=2798&drugname=OxyContin+
Oral&source=1 (last visited Oct. 28, 2012) (the generic name for OxyContin is Oxycodone).
153
See 21 U.S.C.S. § 812(b)(1) (LexisNexis 2011). Schedule I drugs “[have] a high
potential for abuse. . . [have] no currently accepted medical use in treatment, . . . [or] there is a
lack of accepted safety for use of the drug or other substance under medical supervision.” Id.
Thus, Schedule I drugs cannot be prescribed by a doctor under federal law.
154

See Tavernise, supra note 2.

155

What is OARRS?, OHIO AUTOMATED RX REPORTING SYSTEM, https://www.ohiopmp.gov
/portal/Default.aspx (last visited Oct. 28, 2012).
156

Id.

157
See generally Donna Leinwand Leger, States Target Prescriptions by ‘Pill Mills,’ USA
TODAY, http://www.usatoday.com/news/nation/story/2011-10-13/pill-mill-drugtrafficking/50896242/1 (last updated Oct. 25, 2011 11:45 AM) (documenting prescription
monitoring program databases by state). States colored in dark blue have a fully operational
prescription database. Id. States colored in light blue have either proposed enabling
legislation or enacted legislation providing for a prescription database, but no such database is
active. Id. Missouri and Washington D.C., both colored white, have neither enacted nor
proposed legislation to establish a prescription monitoring database. Id.

158

Id.
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Ohio legislature granted the Ohio Pharmacy Board the authority to establish OARRS
in 2005.159 The Ohio Pharmacy Board monitors the database to identify trends of
overmedication, doctor shopping, and abuse.160 These reports can also include
information regarding Ohio patients who had prescriptions filled in other states.161
However, OARRS will only share prescription information with other states’
prescription monitoring programs if they meet Ohio’s statutory requirements and
have signed a written agreement.162 As of the time this Note was written, OARRS
can only interact with the prescription databases of nine other states.163
Currently, “terminal distributors” of medications are required to submit
information to OARRS regarding controlled medications that are dispensed to
patients.164 Terminal distributors are defined as persons engaged in the sale of
“dangerous drugs,” including pharmacies, hospitals, and nursing homes.165 The
information submitted to OARRS includes the name of the patient, the prescriber,
the date of the prescription, medication name, quantity, strength, and dosage.166
With this information, prescribers, pharmacists, and law enforcement may request

159
OHIO REV. CODE ANN. § 4729.75 (LexisNexis 2011) (“The state board of pharmacy may
establish and maintain a drug database. The board shall use the drug database to monitor the
misuse and diversion of controlled substances.”).
160

Id.

161

See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to
Participate, NAT’L ASS’N OF BOARDS OF PHARMACY (Aug. 19, 2011), http://www.nabp.
net/news/ohio-deploys-nabp-pmp-interconnect-statewide-arizona-signs-on-to-participate/.
162

OHIO REV. CODE ANN. § 4729.80(A)(11) (LexisNexis 2011) (“On receipt of a request
from . . . another state's prescription monitoring program, the board may provide to the
requestor information from [OARRS], but only if there is a written agreement under which the
information is to be used and disseminated according to the laws of this state.”); see also
Connecting to PMP InterConnect, NAT’L ASS’N OF BOARDS OF PHARMACY, http://www.nabp
.net/programs/pmp-interconnect/nabp-pmp-interconnect/connecting-to-pmp-interconnect/ (last
visited Oct. 28, 2012). These written agreements are known as a “memorandum of
understanding.” Id. The National Association of Boards of Pharmacy has a model
memorandum drafted which lays out each state’s rights, responsibilities, and privileges with
respect to maintaining the interstate pharmacy database connection. See id.
163
Ohio’s OARRS can interact with the prescription monitoring programs of nine states:
Arizona, Connecticut, Indiana, Kansas, Mississippi, North Dakota, South Carolina, Virginia,
and West Virginia. Noticeably missing from this list are Michigan, Kentucky, and
Pennsylvania—three states that share a border with Ohio. See Ohio Deploys NABP PMP
InterConnect Statewide, Arizona Signs On to Participate, supra note 161.
164

OHIO REV. CODE ANN. § 4729.77 (LexisNexis 2011) (“[E]ach pharmacy licensed as a
terminal distributor of dangerous drugs . . . shall submit to the board the following
prescription information: [prescription information such as patient name, doctor, drug
dispensed, quantity, etc.]”).
165

OHIO REV. CODE ANN. § 4729.01(Q) (LexisNexis 2011).

166

OHIO REV. CODE ANN. §4729.77 (LexisNexis 2011).
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reports regarding medication dispensed to patients in order to better serve the health
of the patient and to protect the public at large.167
In response to the growing prescription abuse epidemic, the Ohio General
Assembly enacted House Bill 93 in 2011.168 This Bill includes prescribers who
dispense drugs (one of the hallmarks of a pill mill) in the definition of “terminal
distributors.”169 Thus, all prescribers who fall into the category of distributors
(including dentists, physician’s assistants, and nurse practitioners) must now report
drug dispenses to OARRS.170 The goal was to make it easier for law enforcement
agencies to identify pill mills without adversely affecting legitimate pain clinics that
properly prescribe controlled medications.171 Specifically, agencies look for trends
of physicians prescribing and dispensing high volumes of narcotic medications paid
for by the patient without any assistance from insurance companies.172
In addition to the changes promulgated by House Bill 93, the Ohio Medical
Board enacted Rule 4731-11-11 in 2011 as part of an effort to go above and beyond
affecting only pain clinics, but to also affect all physicians who prescribe controlled
medications.173 Rule 4731-11-11 requires physicians to review OARRS reports on
patients if “the physician is aware of a patient suffering from addiction, drug abuse,
or engaging in diversion of drugs.”174 Furthermore, physicians must review an
OARRS report on their patient at the beginning of treatment and once annually
thereafter if the patient is being treated for more than twelve weeks.175 These

167

OHIO REV. CODE ANN. § 4729.80 (LexisNexis 2011). Pharmacists and prescribers may
only request reports on patients that they are currently treating. Id. Law enforcement may only
request reports in conjunction with an investigation of a drug offense. Id.
168

See H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at http://www.
legislature.state.oh.us/bills.cfm?ID=129_HB_93; Gov. Kasich Signs House Bill 93, OHIO
NEWS NETWORK (May 20, 2011), http://www.onntv.com/content/stories/2011/05/21/story-pillmills.html (“Gov. John Kasich . . . signed House Bill 93 into law which will now help
legislation that fights Ohio’s prescription drug abuse epidemic.”).
169

See H.B. 93.

170

Id.; see also OHIO ADMIN. CODE 4715-6-01 (LexisNexis 2011) (requiring dentists to
report controlled medication dispenses to OARRS, and to review reports on patients in certain
situations); see also OHIO ADMIN. CODE 4723-9-12 (LexisNexis 2011) (requiring nurse
practitioners to report controlled medication dispenses to OARRS, and to review reports on
patients in certain situations).
171

Zimmer, supra note 20.

172

See generally supra Part II.B.1 (describing the characterization of pill mills).

173

House Bill 93 – New Law to Combat Prescription Drug Abuse, GRAND ROUNDS – YOUR
REPORT FROM THE STATE MEDICAL BOARD OF OHIO (May 2011), available at http://www.med.
ohio.gov/pdf/Newsletters/Spring11_Special_HB93.pdf.
174
175

OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011).

See OHIO ADMIN. CODE 4731-11-11(C) (Lexis Nexis 2011) (“A physician . . . shall, at a
minimum, document receipt and assessment of an OARRS report . . . [o]nce the physician has
reason to believe that the treatment will be required on a protracted basis; and [a]t least once
annually, therafter.”); See OHIO ADMIN. CODE 4731-11-11(A)(4) (Lexis Nexis 2011) (defining
“protracted basis” as “a period in excess of twelve continuous weeks.”).
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measures seek to provide physicians with as much information about their patient’s
medical history as possible before they prescribe a potentially dangerous drug.176
While Rule 4731-11-11 is more stringent than House Bill 93, neither law goes far
enough to prevent prescription drug abuse by patients. Ohio may have created
OARRS to identify trends of prescription abuse, yet not all physicians are required to
run reports from OARRS on controlled substances dispensed to the patient.177 Thus,
physicians, law enforcement agencies, and pharmacists are pulling reports from an
incomplete database. Given the risks of prescription abuse, and the shortcomings of
the current system, a solution that addresses each of these problems is needed.
III. ARGUMENT
Ohio has made great strides to combat prescription drug abuse.178 In spite of
legislative efforts, new laws such as House Bill 93 and Medical Rule 4731-11-11
have shortcomings because they react to the problem of pill mills, instead of
combating prescription abuse generally.179 In addition to these recent changes, the
Ohio legislature should mandate reporting for all controlled medication, make
OARRS interface with the prescription databases of other states, better promote
prescription return programs, and strengthen its laws regarding doctor shopping. By
taking these additional measures, Ohio will more effectively prevent the problem of
prescription drug abuse.
A. Core Competencies of House Bill 93 and Medical Rule 4731-11-11
House Bill 93 and Medical Rule 4731-11-11 are a step in the right direction to
curb prescription abuse for two reasons. First, House Bill 93 makes it very difficult
to operate pill mills, while simultaneously making it easier for healthcare providers
to access OARRS.180 Second, Medical Rule 4731-11-11 mandates OARRS reporting
in some situations, which provides physicians with more information on medications
their patients are already taking.181
1. House Bill 93 Makes It Difficult to Operate Pill Mills in Ohio
House Bill 93 has been effective in closing Ohio’s pill mills.182 In fact, many of
the pill mills in Portsmouth shut down before House Bill 93 took effect.183 These pill
176

See House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173.

177

See generally supra Part II.F (describing who must report to OARRS and what
information must be reported).
178
See generally supra Part II.F (describing laws adopted by Ohio to combat prescription
drug abuse).
179

See House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173.

180

See House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173.

181

See OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011).

182

Noah Adams, A County Takes Down Prescription Pill Mills, NPR (June 19, 2011),
http://www.npr.org/2011/06/19/137284148/a-county-triumphs-over-prescription-pill-mills
(noting that at the time the article was written, all pill mills in Portsmouth had shut down); see
also Alan Johnson, Prayers Answered: Scioto County’s Last ‘Pill Mill’ Shut, COLUMBUS
DISPATCH, http://www.dispatch.com/content/stories/local/2011/12/21/prayers-answeredsciotos-last-pillmillshut.html (Dec. 21, 2011 5:52 AM) (noting that the last pill mill in Scioto
county shut down at the end of 2011).
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mills shut down in part because they did not want to comply with H.B. 93 and Rule
4731-11-11.184 Under H.B. 93, prescribers who actually dispense controlled
medications, rather than merely prescribing medications, must report to OARRS the
controlled medications they dispense.185 This allows Ohio’s Pharmacy Board to
identify pill mills operating under the guise of pain management clinics.186
Additionally, Medical Rule 4731-11-11 requires all pain management clinics to be
licensed to continue operation.187
This licensing requirement allows law
enforcement agencies to monitor pain management clinics without adversely
affecting the clinics that properly prescribe controlled substances and explore
alternative treatment options.188 Finally, under H.B. 93, only physicians may be
licensed to run these clinics.189 This keeps laypersons—who may have ambitions
that contradict a physician’s Hippocratic Oath—out of the practice of medicine.
2. The Recent Changes Also Enable Easier Access to OARRS
House Bill 93 increases healthcare providers’ access to information. All support
staff within a physician’s office can now apply for an account to run OARRS reports
on patients.190 Previously, only prescribers were able to apply for these accounts.191
This change allows physicians to delegate the task of running reports to support
staff.192

183

Adams, supra note 182.

184

Id.

185

OHIO REV. CODE ANN. § 4729.79(A) (LexisNexis 2011). (“If [Ohio] . . . maintains a
drug database . . . , each licensed health professional . . . who personally furnishes a
controlled substance or other dangerous drug . . . to a patient in this state shall submit to the
board the following information: [information about the prescription, including patient name,
doctor name, drug name, dosage, etc.]”); see also H.B. 93, 129th Gen. Assemb., Reg. Sess.
(Oh. 2011), available at http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93
(summarizing the changes brought by House Bill 93).
186
See generally OHIO REV. CODE ANN. § 4729.79(A) (LexisNexis 2011) (providing that
persons who furnish a drug to a patient must report this act to a database controlled by the
Ohio Pharmacy Board).
187

House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173. A pain
management clinic is defined as a place where “[t]he primary component of practice is
treatment of pain or chronic pain; [and t]he majority of patients of the prescribers at the
facility are provided treatment for pain or chronic pain that includes the use of controlled
substances, tramadol, carisoprodol, or other drugs specified in rules adopted under this
section.” OHIO REV. CODE ANN. § 4731.054(A)(5)(a)(i-ii) (LexisNexis 2011).
188

H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at
http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93.
189

House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173.

190

See OHIO REV. CODE ANN. § 4729.80(a)(5) (LexisNexis 2011) (providing agents of the
prescriber the ability to request reports from OARRS).
191

See generally H.B. 93. Prior to House Bill 93, section 4729.80(a)(5) gave only
prescribers and pharmacists the ability to access the database. Id.
192

See OHIO REV. CODE ANN. § 4729.80(a)(5) (LexisNexis 2011).
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Medical Rule 4731-11-11 also works in tandem with House Bill 93 by requiring
pain management physicians to run reports on patients at the inception of treatment
and once annually thereafter.193 The rule obligates physicians to monitor their
patients and ensure that they are not “shopping” elsewhere to get medication.194
Also, this rule establishes a duty to run a report if a physician suspects a patient of
abusing medication.195 Rule 4731-11-11 places more duties on a physician to ensure
patients do not abuse medication.196
B. Shortcomings of H.B. 93 and Rule 4731-11-11
The enactment of House Bill 93 and Rule 4731-11-11 are moves in the right
direction to combat prescription abuse in Ohio. There are problems with these
recent changes, however. First, there are technical issues with these laws. Second,
they react to the problem of pill mills197 but do not adequately address the core of the
prescription abuse problem.
1. Technical Issues with Ohio’s Current Law
Despite the efficacy of H.B. 93 in eliminating pill mills,198 in general the law
does not curb prescription drug abuse.199 Doctor-shopping patients can still visit a
pain clinic, and “explore” alternative treatments, only to find that it “was not
effective” and potentially receive the prescription for the drug of their choice.200
Thus, a patient who never has a real medical need for a medication is free to abuse it,
or sell it on the street.201
Currently, Ohio does not have an adequate “doctor shopping statute.”202
Although Ohio criminalizes procuring medication through deceit (i.e. doctor
shopping) under section 2925.22, case law has only found “deceit” where a patient

193

See OHIO ADMIN. CODE 4731-11-11(C) (Lexis Nexis 2011).

194

Id.

195

See OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011) (setting forth a list of “red
flags” that should trigger suspicions of abuse, such as early refills, requesting brand name
drugs instead of generic, patient appearing to appointment intoxicated, etc.).
196

OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011); H.B. 93, 129th Gen. Assemb.,
Reg. Sess. (Oh. 2011), available at
http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93.
197

See Zimmer, supra note 20.

198

See Adams, supra note 182 (explaining that at the time of the writing of the article, all
pill mills in Portsmouth had shut down).
199

H.B. 93.

200

See H.B. 93. Noticeably absent from the bill is any provision relating to doctor
shopping. See id.
201
See generally supra Part II.C.2 (describing the street prices of prescription drugs and the
temptation of selling them on the street).
202
OHIO REV. CODE ANN. § 2925.22(A) (LexisNexis 2011) (“[n]o person, by deception,
shall procure . . . a dangerous drug . . .”).
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forged a prescription or visited multiple physicians to procure medication.203 Based
on case law, section 2925.22 would be ineffective to prevent “deceit” where a drugseeking patient went to a pain clinic, explored alternate pain management
techniques, but still dishonestly complained of pain.204 Moreover, even if the law
successfully prosecuted doctor shoppers, it could only do so after the patients have
illicitly procured dangerous medications.
However, Ohio cannot easily tighten the grip of section 2925.22. If the
legislature strengthened this law, or put the “burden of proof of pain” on the patient,
patients with real health conditions treatable only by medication could
unintentionally be caught in the web.205 Patients who have a hard time managing
health problems may be justified in using painkillers.206 Further, it would still be
very difficult to find deceit in the case of an interstate doctor shopper, as OARRS
can only interact with the prescription databases from nine other states.207 The
solution to curbing prescription abuse is not to increase the scope of section 2925.22.
Similarly, Rule 4311-11-11 has structural problems. Currently, physicians must
run reports on their patients at the inception of treatment if they believe treatment
will be necessary for twelve weeks or longer, and once annually thereafter.208
Physicians must also review OARRS reports on their patient when they suspect
prescription abuse.209 One year is a long time to wait to run these reports if abuse is
not suspected. Requiring a physician to run these reports more often may prevent an
abuse problem, or catch the problem in its early stages.
House Bill 93 and Rule 4731-11-11 create a loophole in the law when they work
together.210 First, House Bill 93 does not require the physician to report information
in OARRS if a physician does not dispense medication to a patient.211 Additionally,
203
Cf. State v. O'Connell, 2011-Ohio-652, 655 (Ohio Ct. App. 2011); State v. Hartney,
2010-Ohio-4331, 4332-33 (Ohio Ct. App. 2010); State v. Newland, 2009-Ohio-1340, 1341-43
(Ohio Ct. App. 2009). In these cases, deceit could be proven where the defendant visited
multiple doctors to obtain prescriptions of pain medications, and these doctors did not know
about the existence of the other doctors. No case can be found on point where deceit was
alleged when a patient had only one doctor.
204

OHIO REV. CODE ANN. § 2925.22(A) (LexisNexis 2011).

205

See Lowes, supra note 105. Although discussing prescription abuse in the context of
Medicare fraud, the same tension exists here. The author notes in the article that if Medicare
regulations were tightened to prevent medication abuse, patients with legitimate and
complicated problems who see four or five specialists to treat their condition could be caught
in the web. Id.
206

Id.

207

See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to
Participate, supra note 161 (explaining that OARRS can interact with the prescription
monitoring programs in Arizona, Connecticut, Indiana, Kansas, Mississippi, North Dakota,
South Carolina, Virginia, and West Virginia).
208

See OHIO ADMIN. CODE 4731-11-11(C) (Lexis Nexis 2011).

209

OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011).

210

See H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at
http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93l; OHIO ADMIN. CODE 4731-1111(C) (Lexis Nexis 2011).
211

OHIO REV. CODE ANN. § 4729.79 (LexisNexis 2011).
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Rule 4731-11-11 only requires physicians to review an OARRS report at the
inception of a twelve-week or longer treatment.212 Therefore, if a patient visits
multiple physicians on a short-term basis to receive controlled medications, the
patient’s drug-seeking behaviors may go undetected. A patient’s drug-seeking
behavior may only be uncovered when a patient fills a prescription at an Ohio
pharmacy, because once a prescription is filled, it will be reported to OARRS.213
However, OARRS cannot report on this information, and, therefore, OARRS users
are running reports on an incomplete database if a patient fills a prescription in
Kentucky, or any of the 39 other states incompatible with OARRS.214 Thus, a
patient’s healthcare provider, as well as Ohio’s law enforcement agencies, may be
oblivious to all medications a patient receives. This is especially troubling when
Scioto County, Ohio—a county with a high rate of opiate consumption—215 borders
with Kentucky, which has similar prescription abuse problems.216 Thus, the Ohio
legislature should fill this statutory hole, or promote pharmacy database
communications between Ohio and other states in order to effectively combat
prescription abuse.
2. Reactive
Ohio’s recent changes are also reactive to the epidemic of pill mills. While
House Bill 93 removes one source of prescriptions in Ohio, there is more that could
have been done. Neither House Bill 93 nor Medical Rule 4731-11-11 identify
patients who receive a modest supply of drugs from only one physician and either
abuse the medicine or sell it on the street.217 Conversely, these laws are partially
successful in curbing doctor shopping because they require prescribers to report

212

See OHIO ADMIN. CODE 4731-11-11(C) (LexisNexis 2011).

213

OHIO REV. CODE ANN. § 4729.77 (LexisNexis 2011) (setting forth requirement that
pharmacies report prescription information to OARRS).
214
See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to
Participate, supra note 161 (indicating that OARRS can interact with the prescription
monitoring programs in Arizona, Connecticut, Indiana, Kansas, Mississippi, North Dakota,
South Carolina, Virginia, and West Virginia). But see Leger, supra note 157 (mentioning that
OARRS can interact with Kentucky’s KASPER). Given this discrepancy, and the
memorandum of understanding between Kentucky and Ohio, it appears the Kentucky and
Ohio have agreed in theory to share prescription information, but have not yet performed the
necessary technical work to connect the databases.
215
See generally Ohio’s Opiate Epidemic: User Profiles, supra note 86 (table displaying
prescription opiate consumption per capita in each of Ohio’s counties).
216
See generally Politicians, Physicians Should Lead Fight Against Ky. Pill Mills,
KENTUCKY.COM (Nov. 15, 2011), http://www.kentucky.com/2011/11/15/1960000/politiciansphysicians-should.html (describing generally the problems Kentucky faces with pill mills); cf.
Tavernise, supra note 2 (describing generally the havoc wrought in Southern Ohio by pill
mills).
217

See H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at http://www.
legislature.state.oh.us/bills.cfm?ID=129_HB_93l; OHIO ADMIN. CODE 4731-11-11(C)
(LexisNexis 2011).
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controlled medications dispensed to OARRS in all situations, but require reports to
be run only in some situations.218
Rule 4731-11-11 is more effective in combating doctor shopping opposed to
H.B. 93. However, the rule still falls far short to tackle the problem head-on. For
example, Rule 4731-11-11 requires physicians to view OARRS reports on their
patients when they suspect their patients of abusing medications or suspect that the
patient will be treated with a controlled substance for more than twelve weeks.219
These rules are easily circumvented. First, the requirement that physicians view
reports on their patients where abuse is suspected is based partially on the
physician’s subjective belief.220 The physician could easily circumvent the rule
simply by saying, “I did not think my patient was abusing medications.”221 Second,
an ill-intentioned physician may agree to only treat a patient with controlled
medications for less than twelve weeks.222
Ohio’s current statutory scheme also does not effectively prevent the cycle of
abuse. While H.B. 93 removes pill mills as a source of prescriptions for patients, it
does not attack the root problem, namely, stopping patients from abusing
medications. Further, physicians may prescribe a controlled medication, such as
Oxycontin, to their patient in good faith, when in reality that patient was simply
shopping for medication. If this physician failed to investigate a patient’s medical
history and this patient was doctor shopping, the physician could be liable for failing
to investigate the patient’s medical history.223 This illustrates that “[t]he problem
with the current legislation is that [Ohio’s] criminal sanctions represent reactive
218

“[E]ach licensed health professional . . . who personally furnishes a controlled substance
or other dangerous drug . . . to a patient in this state shall submit to the board the following
information . . . ” OHIO REV. CODE ANN. § 4729.79(A) (LexisNexis 2011); OHIO ADMIN. CODE
4731-11-11(B) (LexisNexis 2011) (delineating the situations that require prescribers to view
OARRS reports on their patients).
219

See OHIO ADMIN. CODE 4731-11-11(B) (LexisNexis 2011) (“If a physician believes or
has reason to believe that a patient may be abusing or diverting drugs, the physician shall use
sound clinical judgment in determining whether or not the reported drug should be prescribed
or personally furnished to the patient under the circumstances.”); OHIO ADMIN. CODE 4731-1111(C) (LexisNexis 2011) (“A physician prescribing . . . reported drugs to treat a patient on a
protracted basis shall, at a minimum, document receipt and assessment of an OARRS report . .
. [a]t least once annually . . .”). Further, a “protracted basis” is defined as “a period in excess
of twelve continuous weeks.” OHIO ADMIN. CODE 4731-11-11(A)(4) (LexisNexis 2011).
220
“If a physician believes or has reason to believe that a patient may be abusing or
diverting drugs . . . the physician shall access OARRS.” OHIO ADMIN. CODE 4731-1111(B)(1) (LexisNexis 2011).
221
At the time this Note was written, Rule 4731-11-11 had just taken effect and therefore
had not yet been interpreted by Ohio case law.
222
OHIO ADMIN. CODE 4731-11-11(C) (Lexis Nexis 2011) (requiring that doctors must
review patient reports if treating for twelve weeks). Thus, if a doctor treats a patient for only
eleven weeks, there is no duty to run an OARRS report on a patient.
223
OHIO ADMIN. CODE 4731-11-11(B)(1) (Lexis Nexis 2011). A physician must review an
OARRS report if he “believes or has reason to believe that a patient may be abusing or
diverting drugs.” Id. Because the regulation is so new, there is no case law yet elaborating or
providing examples of when the physician “had reason to believe” her patient was abusing or
diverting prescription medications.
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remedies because penalties can only be imposed after a finding of unlawful
distribution . . .”224 While sanctions for breaking the law may convince prescribers
and patients to follow it, “a reactive remedy cannot retroactively repair any damage
which the unlawfully prescribing physician may have caused in the way of physical
and psychological dependence in addicted victims.”225 Thus, Ohio needs a solution
that prevents prescription drug abuse before the damage to the patient is done.
House Bill 93 does not prevent injury to patients. As noted above, it requires
prescribers who furnish drugs to patients to report this activity to OARRS.226 While
the Ohio Pharmacy Board will monitor this database for trends of overmedication,
doctor shopping and abuse, prescribers do not need to monitor the database in many
situations.227 Prescribers, who are in the best position to identify signs of patient
drug abuse, are not required in all situations to review an OARRS report on their
patient, which will delineate all controlled medications received by the patient in the
last two years.228 And before a trend is identified by law enforcement an illintentioned patient could have either amassed a large quantity of drugs to sell on the
street, or harmed themselves by taking these drugs.229 Regardless, the damage is
already done before the pharmacy board can take action. Thus, Ohio should instead
adopt a solution that can stop the problem of medication abuse before another
situation similar to the “Portsmouth” problem happens elsewhere in Ohio.
C. Proposed Solution
As shown above, prescription drug abuse is a complex problem in Ohio that has
life altering consequences, is extremely costly, and is a problem not adequately
addressed by Ohio’s current legislation.230
Further, Ohio’s law addressing
prescription drug abuse is confusing regarding who has to review reports on their
patients and when.231 Thus, more needs to be done to help prevent abuse. The first
step would be to require mandatory OARRS monitoring for all controlled
224

David L. Robinson, Bridging the Gaps: Improved Legislation to Prohibit the Abuse of
Prescription Drugs in Virginia, 9 APPALACHIAN J. L. 281, 282 (2010). Although this law
review article discusses Virginia’s challenges with prescription abuse, Ohio has similar
challenges.
225

Id.

226

OHIO REV. CODE ANN. § 4729.79 (LexisNexis 2011).

227

OHIO REV. CODE ANN. § 4729.75 (LexisNexis 2011); OHIO ADMIN. CODE 4731-1111(B) (LexisNexis 2011).
228

OHIO REV. CODE ANN. §§ 4729.77–.79 (LexisNexis 2011).

229

See generally supra Part II.C.2 (describing the danger and temptation of selling
prescriptions on the street). See also Lowes, supra note 105 (discussing case studies of
patients amassing large quantities of drugs).
230
231

See supra Part III.B.1–2.

Cf. OHIO ADMIN. CODE 4731-11-11(C) (LexisNexis 2011) (requiring doctors to review
patient reports if treating for more than twelve weeks); OHIO ADMIN. CODE 4731-11-11(B)
(LexisNexis 2011) (requiring doctors to review OARRS patient reports if they suspect abuse);
OHIO REV. CODE ANN. § 4729.79 (LexisNexis 2011) (requiring prescribers to submit reports to
OARRS if they physically dispense medications to a patient, with no requirement to run a
report).
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medications. This includes running reports on patients before medication is
prescribed, and reporting to OARRS the controlled medications that were dispensed.
The second step would require OARRS to interact with the prescription monitoring
programs of other states. The third step is to better promote the current pharmacy
take back programs. The final step would be to create a stronger anti-doctor
shopping statute. While these suggestions are not a panacea to end Ohio’s
prescription abuse epidemic, they more effectively remove the fuel to the fire of
prescription abuse, instead of simply treating the symptoms of abuse.
1. Mandatory OARRS Monitoring
Given the nature of Ohio’s drug abuse problem, the Ohio legislature should
require all physicians to run OARRS reports on their patients before writing
prescriptions for controlled medication, and report to OARRS controlled
medications prescribed to patients. As previously mentioned, H.B. 93 allows hospital
support staff to sign up for OARRS,232 which would decrease the administrative
burden on physicians.233 The Ohio State Board of Pharmacy already offers access to
OARRS to practitioners and pharmacists at no cost.234 The information from these
free reports would allow physicians to quickly and efficiently identify the drugseeking behaviors of their patients.235 Physicians would then have the necessary tools
to make prescribing decisions in the best interests of their patient’s health.
In order to establish these requirements, Ohio first needs to amend O.R.C.
Sections 4729.79 and 4729.80(A)(5). Section 4729.79 currently reads:
(A) If the state board of pharmacy establishes and maintains a drug
database . . . , each licensed health professional authorized to prescribe
drugs, other than a veterinarian, who personally furnishes a controlled
substance or other dangerous drug the board includes in the database
pursuant to rules adopted under section 4729.84 of the Revised Code to a
patient in this state shall submit to the board the following information:
(1) Prescriber identification;
(2) Patient identification;
(3) Date drug was furnished by the prescriber;
(4) Indication of whether the drug furnished is new or a refill;
(5) Name, strength, and national drug code of drug furnished;
(6) Quantity of drug furnished;
(7) Number of days’ supply of drug furnished;

232
See OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011) (providing agents of the
prescriber the ability to request reports from OARRS).
233

See generally supra Part III.A (discussing the positive changes that House Bill 93 and
Medical Rule 4731-11-11 bring).
234

William T. Winsley & Donna E. Droz, Ohio’s Dangerous Drug Database Past,
Present, and Future: House Bill 93 Report, OHIO STATE BOARD OF PHARMACY AUTOMATED
(November 21, 2011), https://www.ohiopmp.gov/portal/docs.aspx (follow “Legislative Report
for HB 93” hyperlink).
235

See Tribble, supra note 113 (“If doctors were required to check the database, they
would spot patients who were pill shopping, going to multiple pain clinics and emergency
rooms to obtain prescriptions or samples.”).
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(8) Source of payment for the drug furnished.236
The Ohio legislature should amend Section 4729.79(A) to read (changes in
italics):
(A) If the state board of pharmacy establishes and maintains a drug
database . . . , each licensed health professional authorized to prescribe
drugs, other than a veterinarian, who personally furnishes or prescribes a
controlled substance or other dangerous drug the board includes in the
database pursuant to rules adopted under section 4729.84 of the Revised
Code to a patient in this state shall submit to the board the following
information:
(1) Prescriber identification;
(2) Patient identification;
(3) Date drug was furnished or prescribed by the prescriber;
(4) Indication of whether the drug furnished or prescribed is new or a
refill;
(5) Name, strength, and national drug code of drug furnished, and name
and strength of drug prescribed;
(6) Quantity of drug furnished or prescribed;
(7) Number of days’ supply of drug furnished or prescribed;
(8) Source of payment for the drug furnished.
Essentially, Section 4729.79(A) would be amended to include “or prescribe”
anywhere the word “furnished” appears. This would provide that all controlled drugs
prescribed are reported to OARRS. Thus, if a patient fills their prescription out of
state, OARRS will still have information that a patient may have received the drug.
While reporting controlled medications prescribed to OARRS may seem daunting at
first, many physicians’ offices already store records electronically, and have even
begun to send prescriptions via email.237 Some states similarly require prescribers to
send their prescriptions electronically to pharmacies, which has the added benefit of
ensuring accuracy and tracking whether a prescription was filled.238 If Ohio enacted
a similar requirement, prescribers would need to submit the same information to the
pharmacy board.
However, requiring that prescribers report medications prescribed is not enough.
The Ohio legislature needs to also require that all physicians monitor reports on their
patients before prescribing or dispensing a controlled medication. As a result,
physicians will be able to see what controlled medications their patient is taking, as
well as prescriptions they may have received from an Ohio physician, but were filled

236

OHIO REV. CODE ANN. § 4729.79 (LexisNexis 2011).

237

See Associated Press, New York Lawmakers OK Electronic Drug Prescriptions Bill,
SYRACUSE.COM (June 11, 2012, 7:20 PM), http://www.syracuse.com/news/index.ssf/
2012/06/new_york_lawmakers_ok_electron.html (“[D]octors already are moving toward
writing prescriptions electronically. . .”).
238
See id. (discussing New York’s requirement that physicians must electronically submit
prescriptions to pharmacies within three years).
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in another state.239 To make this a requirement, the Ohio Legislature needs to amend
Section 4729.80(A)(5). This section currently reads:
(A) If the state board of pharmacy establishes and maintains a drug
database . . . the board is authorized or required to provide information
from the database . . . :
(5) On receipt of a request from a prescriber or the prescriber’s agent
registered with the board, the board may provide to the prescriber
information from the database relating to a current patient of the
prescriber, if the prescriber certifies in a form specified by the board that
it is for the purpose of providing medical treatment to the patient who is
the subject of the request.240
The Ohio legislature should amend Section 4729.80(A)(5) to read (changes in
italics):
(A) If the state board of pharmacy establishes and maintains a drug
database . . . the board is authorized or required to provide information
from the database . . . :
(5) On receipt of a request from a prescriber or the prescriber’s agent
registered with the board, the board must provide to the prescriber
information from the database relating to a current patient of the
prescriber, if the prescriber certifies in a form specified by the board that
it is for the purpose of providing medical treatment to the patient who is
the subject of the request. Such request shall be made by the prescriber or
the prescriber’s agent registered with the board if the doctor is currently
treating the patient with a controlled drug as defined by the Controlled
Substances Act (21 U.S.C.S. § 812) or a dangerous drug.
Under the proposed Section 4729.80(A)(5), prescribers who treat their patients
with controlled medications would now be required to monitor OARRS reports on
their patients. The changes to this section include replacing “may” with “must.”
Specifically, the pharmacy board was previously not required to provide OARRS
reports to requesting physicians.241 Still, some practitioners are concerned that
monitoring OARRS reports on patients can be time-consuming.242 But, the Ohio
State Board of Pharmacy has reported that 99.5% of all report requests in 2011 were
processed in less than three seconds, which directly contradicts this criticism.243
Under this proposal, medical support staff can reliably request OARRS reports on all
239

See infra Part III.C.2 (discussing the challenges of ascertaining medications a patient
received in another state, and a solution to that challenge).
240

OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011).

241

See id. (“On receipt of a request from a prescriber or the prescriber’s agent registered
with the board, the board may provide to the prescriber . . . .” (emphasis added)).
242
Cf. Zimmer, supra note 20 (“[D]octors have issues with the cumulative time
commitment of system checks. Others have criticized it for the lag time between when a
prescription is filled and when that activity actually appears in the database.”); Tribble, supra
note 113 (arguing that OARRS reporting “would hit doctors at a time when they are seeing
more patients and implementing their own electronic medical records.”).
243

See Winsley & Droz, supra note 234.
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patients the physician will consult with at the beginning of the day. Thus, the
physician will have OARRS information on all of their patients before patients
arrive.
The proposed amendment to Section 4729.80(A)(5) also includes language from
House Bill 93. Specifically, it notes that either the physician, or the physician’s
support staff can make reports.244 In addition, this proposed change incorporates
terms of art from the definitions of Section 4729(F). Specifically, “Dangerous Drug”
is defined as:
(F) “Dangerous drug” means any of the following:
(1) Any drug to which either of the following applies:
(a) Under the “Federal Food, Drug, and Cosmetic Act,” 52 Stat. 1040
(1938), 21 U.S.C.A. 301, as amended, the drug is required to bear a label
containing the legend “Caution: Federal law prohibits dispensing without
prescription” or “Caution: Federal law restricts this drug to use by or on
the order of a licensed veterinarian” or any similar restrictive statement,
or the drug may be dispensed only upon a prescription;
(b) Under Chapter 3715. or 3719. of the Revised Code, the drug may be
dispensed only upon a prescription.
(2) Any drug that contains a schedule V controlled substance and that is
exempt from Chapter 3719. of the Revised Code or to which that chapter
does not apply;
(3) Any drug intended for administration by injection into the human
body other than through a natural orifice of the human body.245
Under the proposed change, the use of the term “controlled drug” captures any
drug that the FDA has classified as “dangerous.”246
The mandatory monitoring requirement could also be codified within the Ohio
Administrative Code. In order to establish these requirements, Ohio can amend
Medical Rule 4731-11-11,247 Dental Rule 4715-6-01,248 and Nursing Rule 4723-912.249 These rules propagated by the Ohio Medical, Dental, and Nursing Boards
delineate situations in which prescribers should review OARRS reports on their
patients before prescribing controlled medications.250 Instead, the rule should require
244
See OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011) (providing agents of the
prescriber the ability to request reports from OARRS); see supra Part III (describing positive
changes of H.B. 93, one of which being access to OARRS by medical support staff).
245

OHIO REV. CODE ANN. § 4729.01(F) (LexisNexis 2011).

246

21 U.S.C.S. § 812(c) (LexisNexis 2011) (listing all drugs the FDA has listed as
“controlled”).
247

OHIO ADMIN. CODE 4731-11-11 (LexisNexis 2011).

248

OHIO ADMIN. CODE 4715-6-01 (LexisNexis 2011).

249

OHIO ADMIN. CODE 4723-9-12 (LexisNexis 2011).

250

See e.g. OHIO ADMIN. CODE 4731-11-11(B)(1) (LexisNexis 2011) (requiring physicians
to review an OARRS report on patients in certain situations before prescribing a controlled
drug); OHIO ADMIN. CODE 4715-6-01(B)(1) (LexisNexis 2011) (requiring dentists to review an
OARRS report on patients in certain situations before prescribing a controlled drug); OHIO
ADMIN. CODE 4723-9-12(B)(1) (LexisNexis 2011) (requiring nurse practitioners to review an
OARRS report on patients in certain situations before prescribing a controlled drug).
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prescribers to review OARRS reports on their patients in all situations before
prescribing a controlled drug.
Mandatory controlled prescription monitoring is not a novel idea. New York’s
legislative branch recently passed a similar requirement, known as The Internet
System for Tracking Over-Prescribing Act (“I-STOP”).251 I-STOP has not yet been
signed into law in New York, although it did pass both the state Senate and House of
Representatives, and Governor Cuomo supported the effort to pass I-STOP.252
While the initiative is obviously too new to discern the ramifications of I-STOP, it
will likely curb prescription abuse because physicians will now review a patient’s
controlled medication history, before prescribing new controlled drugs. Thus, under
New York’s proposed law, if a patient previously received a month’s supply of a
controlled drug from a prescriber, a new prescriber will have access to, and will be
required to review, that information before prescribing the patient the same or a new
controlled drug.253 Because mandatory OARRS monitoring only provides
information to physicians, it cannot prevent abuse where physicians willfully ignore
this information.
While amending Section 4729.80(A)(5) and sections of the Ohio Administrative
Code is a step in the right direction, it is naïve in that the solution anticipates all
physicians will only prescribe medically necessary controlled medications to their
patients. Thus, mandatory reporting is ineffective in situations where a physician and
patient work together to feed a patient’s addiction. A well-known example is the
previously mentioned death of Michael Jackson.254 The medications that caused
Jackson’s death were prescribed and administered by his personal physician,255 who
was found guilty of involuntary manslaughter.256
251
New York Passed Legislation Requiring E-Prescribing Software, DAW SYSTEMS, INC.
(June 29, 2012), http://dawsystems.com/news/e-prescribing-legal-news/new-york-passedlegislation-requiring-e-prescribing-software/ (“This is the first state in the country to mandate
that doctors observe patient's medical history and previous prescriptions before assigning
schedule II, III or IV controlled substances.”).
252

See Dan Herbeck, Welcoming Legal Remedy to Prescription Drug Nightmare, BUFFALO
NEWS (Jul. 12, 2012, 12:05 AM), http://www.accessmylibrary.com/article-1G1296348490/welcoming-legal-remedy-prescription.html; see also Internet System For Tracking
Over-Prescribing Act S-7637-2011(D)(2), NYSENATE.GOV, http://open.nysenate.gov/legis
lation/bill/S7637-2011 (last visited Dec. 4, 2012); New York Passed Legislation Requiring EPrescribing Software, supra note 251 (noting that state legislators passed I-STOP in June,
2012).
253

See Internet System For Tracking Over-Prescribing Act S-7637-2011(D)(2), supra note

252.
254

See supra Part II.A.2 (discussing Michael Jackson’s death that was caused by
tranquilizers).
255
256

See Wedro, supra note 63.

See Karen Grigsby Bates, Jury Finds Dr. Murray Guilty in Pop Star’s Death, NPR
(Nov. 8, 2011), http://www.npr.org/2011/11/08/142123505/jury-finds-dr-murray-guilty-inpop-stars-death; see also Alan Duke, Conrad Murray Sentenced to Four Years Behind Bars,
CNN (Nov. 30, 2011, 5:46 AM), http://www.cnn.com/2011/11/29/justice/california-conradmurray-sentencing/index.html (reporting that Dr. Murray, the doctor who prescribed the drugs
that killed Michael Jackson, was sentenced to prison for four years).
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Still, despite some of the limitations of mandatory OARRS reporting, such
reporting has additional benefits outside the scope of preventing prescription abuse.
For example, a specialist could have access to a patient’s controlled medication
history for the last two years.257 This would allow this physician to make decisions in
the best interest of the patient by prescribing medications based on potential drug
interactions. In a similar vein, physicians in emergency rooms will have complete
prescription information on a patient that they are treating.258 Having such
information would lead to better healthcare for all patients. Despite the benefits of
mandatory OARRS reporting, practitioners still would only have access to patient
prescription information from Ohio.
2. Interstate OARRS Connectivity
Under today’s system, mandatory OARRS reporting will not likely prevent
prescription abuse where patients receive drugs in another state. Currently, OARRS
can only interact with the prescription databases in nine other states.259 Thus,
physicians can only see the medications a patient receives in those states.260
To make mandatory prescription reporting truly effective, OARRS should
communicate with the prescription databases of all states.261 Currently, there is no
single database that handles a prescription-monitoring program (“PMP”).262 Thus, it
would seemingly be challenging and expensive to make the database of one state
communicate with the database of another state.263 Currently, OARRS can interface
with the PMPs of Arizona, Connecticut, Indiana, Kansas, Mississippi, North Dakota,
South Carolina, Virginia, and West Virginia.264 Noticeably missing from this list is
Kentucky, Pennsylvania, and Michigan, which share a border with Ohio. Patients
living in a southern Ohio city, such as Portsmouth, could have prescriptions filled in
Kentucky and OARRS would not be able to report this information. Even though
Ohio eliminated pill mills with the enactment of H.B. 93, patients can still go to an
out of state pill mill to obtain controlled medications such as Oxycontin. Ohioans
can depend on out of state pill mills because Ohio’s law enforcement agencies, and

257

See supra, Part III.B.1–2.

258

See supra, Part III.B.1–2.

259

See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to
Participate, supra note 161.
260
See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to
Participate, supra note 161.
261

See supra Part III.B.1 (discussing the limitations of a prescription database that cannot
interact with the prescription databases of other states).
262

See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to
Participate, supra note 161. While not directly stated, this can be inferred because OARRS is
able to interact with the databases from only nine other states. If there was a single database
that managed this process, OARRS would likely interact with more than just nine other states.
263
See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to
Participate, supra note 161.
264
See infra Part III.C.2 (proposing that OARRS should interact with the PMPs of other
states).
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more importantly, the Ohio patient’s physician, would be oblivious to the
medications a patient receives out of state.
Because of the limitations of the current system, the Ohio legislature should
appropriate resources to Ohio’s Board of Pharmacy, which manages OARRS.265
Currently, OARRS is funded entirely by federal grants.266 With these additional
state resources, the Pharmacy Board could fully utilize OARRS by interacting with
the PMPs of other states, such as Kentucky’s KASPER.267 Interacting Kentucky’s
PMP system with Ohio OARRS system is especially important not only because
Kentucky has similar prescription abuse problems as Ohio, but also because
Kentucky shares a border with Ohio.268 Interstate connectivity of prescription
databases would prevent doctor shoppers living near state borders from filling
prescriptions in multiple states, unbeknownst to authorities. Promoting interstate
reporting would also add teeth to Ohio’s 2925.22, which can only prevent “deceit” in
Ohio and nine other states with whom OARRS connects with.269 While interstate
OARRS reporting would be beneficial, it is not a cure-all for Ohio’s “interstate
doctor shopping” problem, unless each state similarly required physicians to use
their respective databases to report controlled medications prescribed to patients.270
Thus, amending Section 4729.80(A)(5), as proposed in the previous section, would
only be as effective as other states’ stances on prescription drug abuse.271
265

OHIO REV. CODE ANN. § 4729.75 (LexisNexis 2011) (“The state board of pharmacy may
establish and maintain a drug database. The board shall use the drug database to monitor the
misuse and diversion of controlled substances. . .”).
266

See Winsley & Droz, supra note 234.

267
KASPER (Kentucky All Schedule Prescription Electronic Reporting), KENTUCKY
CABINET FOR HEALTH AND FAMILY SERVICES, http://chfs.ky.gov/os/oig/KASPER.htm (last
updated Sept. 21, 2012); see also Leger, supra note 157. While Ohio and Kentucky have a
memorandum of understanding, the prescription monitoring programs of these states do not
yet communicate with each other. Id.
268

See generally Politicians, Physicians Should Lead Fight Against Ky. Pill Mills, supra
note 216 (describing the problems Kentucky faces with pill mills); cf. Tavernise, supra note 2
(describing the havoc wrought in Southern Ohio by pill mills).
269

See supra Part III.B.1 (describing the shortcomings of Ohio’s “doctor shopper” statute).

270

E.g., KY REV. STAT. ANN. § 218A.202(3) (LexisNexis 2011) (showing that similar to
Ohio, Kentucky requires only dispensers and not prescribers to report prescription data to
KASPER; but OARRS cannot share information with KASPAR because there is no
memorandum of understanding); 28 PA. CODE § 25.131 (Lexis Nexis 2011) (showing that
Pennsylvania only requires pharmacies to report on Schedule II substances like Oxycontin, but
not Schedule III to V substances); IN. CODE ANN. § 35-48-7-8.1 (LexisNexis 2011) (showing
that similar to Ohio, Indiana requires only dispensers and not prescribers to report prescription
data to INSPECT); MICH. ADMIN. CODE R. 338.3162d (LexisNexis 2011) (showing that
similar to Ohio, Michigan requires only dispensers and not prescribers to report prescription
data to its prescription monitoring program; but OARRS cannot share information with
Michigan’s database because there is no memorandum of understanding); see also Ohio
Deploys NABP PMP InterConnect Statewide, Arizona Signs On to Participate, supra note 161
(listing the different states that OARRS can interact with, included in the list is Indiana).
271

See supra Part III.C.1 (proposing that Ohio legislature amend Section 4729.80(A)(5) to
require all physicians to report controlled medications prescribed to patients to OARRS); see
generally, Interstate Sharing of Prescription Monitoring Database Information, NATIONAL
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3. Unused Prescription Collections
A third solution to help curb prescription drug abuse would be to “take back”
unused prescription medications.272 The DEA currently has a program to collect
unused medications.273 The premise of this program is that the DEA will host
collection centers for people to bring their unused prescriptions to get these drugs off
of the street.274 The DEA will then destroy the medications in a safe way.275 Ohio
has established a similar drug “take back” program under House Bill 93.276 The
effectiveness of this newly established program in removing excess prescription
drugs from the street remains to be seen. Recent drug “take back” programs have had
promising results as did one in Cleveland, Ohio where over four tons of medications
were collected.277 Where community resources are limited, commentators have
proposed retail pharmacy-based programs, where patients would be more likely to
return medications.278 The pharmacy would then turn these drugs into the DEA for
destruction.
Removing prescription drugs from the street would reduce the instances of
prescription drug abuse originating in the home.279 While this will not stop the abuse
problem entirely, because not all persons will turn in their unused medications,
decreasing the amount of drugs on the street will certainly help to curb abuse.
4. Anti-Doctor Shopper Statute
The Ohio legislature should also effectively punish the act of doctor shopping.
Ohio currently does not effectively criminalize the act of obtaining prescriptions
through fraud.280 While most of this Note advocates prevention-oriented legislation,
backward looking statutes can also effectively prevent drug abuse if used properly.
ALLIANCE FOR MODEL STATE DRUG LAWS (Oct. 17, 2011), available at http://www.namsdl
.org/documents/InterstateSharingofPMPInformation10.14.2011.pdf (surveying the enabling
prescription monitoring program laws of various states).
272

See supra Part III.

273

National Take Back Initiative, OFFICE OF DIVERSION CONTROL, DRUG ENFORCEMENT
AGENCY, http://www.deadiversion.usdoj.gov/drug_disposal/takeback/index.html (last visited
Dec. 4, 2012).
274

See id.; Donaldson, supra note 134.

275

See Donaldson, supra note 134.

276

See OHIO REV. CODE ANN. § 4729.69(A) (LexisNexis 2011) (“The state board of
pharmacy, in collaboration with the director of alcohol and drug addiction services and
attorney general, shall establish and administer a drug take-back program under which drugs
are collected from the community for the purpose of destruction or disposal of the drugs.”).
277

See Donaldson, supra note 134.

278

See Robert J. Greenwood, Commentary on “Drug Take-Back Programs Are Safe,
Clean”, NCPANET.ORG, http://www.ncpanet.org/index.php/ncpa-commentary/913commentary-on-qdrug-take-back-programs-are-safe-cleanq (last visited Dec. 4, 2012); Issues,
THE DRUG TAKE-BACK NETWORK, http://www.takebacknetwork.com/issues.html (last visited
Dec. 4, 2012).
279

See generally supra Part II.D.3 (identifying dangers of prescriptions found in the home).

280

See supra Part III.B.1 (discussing Ohio’s § 2925.22 and its ineffectiveness).
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Specifically, an anti-doctor shopper statute used in conjunction with mandating
physician OARRS reporting for controlled medications can be a useful tool to
prevent prescription abuse.281 In this way, Ohio can prevent prescription abuse that
is initiated by a patient.
Florida currently criminalizes the act of obtaining prescriptions through fraud.282
The Florida statute differs from Ohio’s Section 2925.22 in that it specifically
prevents patients from doctor shopping.283 Florida’s Section 893.13(7)(a)(8)
mandates that a patient cannot withhold that they “received a controlled substance or
a prescription for a controlled substance of like therapeutic use from another
practitioner within the previous 30 days.”284 Further, “withholding” has been
interpreted to mean “hold back,” as such a patient must volunteer to a prescriber that
they recently received a controlled medication from a different prescriber, regardless
of whether the prescriber specifically asks for this information.285 Although
Florida’s doctor shopping statute criminalizes this activity, it would be difficult to
enforce in Ohio under the current statutory system.286 Without a mandatory
reporting requirement, physicians would only know that their patients are shopping
if the physicians happened to run a report on their patients. Accordingly, if Ohio
were to enact legislation similar to Florida’s Section 893.13(7)(a)(8), it would only
be truly effective if the burden was on the prescribers and patients. Effective
legislation would require a prescriber’s burden to run reports up front and a patient’s
burden to affirmatively disclose all medications they were taking before receiving a
prescription for controlled medications.
D. Debunking the Criticism of OARRS by Practitioners and Patients
Despite the potential wealth of information OARRS contains, healthcare
professionals cite many reasons as to why they choose not use these reports. Some
critics point to the burden of running OARRS reports on patients.287 Others are
281

See generally supra Part III.C.1 (proposing that Ohio mandate OARRS reporting for
controlled medications).
282

FLA. STAT. ANN. § 893.13(7)(a)(8)–(9) (LexisNexis 2011).

283

Knipp v. State, 67 So. 3d 376, 379 (Fla. Dist. Ct. App. 4th Dist. 2011) (interpreting that
a patient’s failure to affirmatively disclose prior requests to receive a controlled medication is
a violation of section 893.13(7)(a)(8)). But cf. OHIO REV. CODE ANN. § 2925.22(A)
(LexisNexis 2011) (“[n]o person, by deception, shall procure . . . a dangerous drug . . . .”);
State v. O'Connell, 2011-Ohio-652, ¶3 (Ohio Ct. App. 2011) ; State v. Hartney, 2010-Ohio4331, ¶¶2-3 (Ohio Ct. App. 2010); State v. Newland, 2009-Ohio-1340, ¶¶2-4 (Ohio Ct. App.
2009) (finding deception shown where patient affirmatively lied about medications she was
taking.).
284

FLA. STAT. ANN. § 893.13(7)(a)(8) (LexisNexis 2011).

285
Knipp, 67 So. 3d at 379 (“Whether an individual has actually withheld information in
violation of the statute depends on whether s/he requested a controlled substance and failed to
disclose the fact that s/he received a drug of like therapeutic use within the previous thirty
days. In other words, the statute requires that an individual affirmatively requesting a
substance provide information to the practitioner.”).
286
287

See supra Part III.B.1 (discussing inadequacy of statute in regards to doctor shopping).

Cf. Zimmer, supra note 20 (“doctors have issues with the cumulative time commitment
of system checks. Others have criticized [the system] for the lag time between when a
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concerned with the privacy issues of maintaining a patient database filled with
information relating to a patient’s healthcare.288 As shown below, these criticisms
are either untenable or do not outweigh the benefit of having such a system in place.
Some criticize the slow response time it takes to run a report, and thus the
argument follows that physicians have less time to effectively treat patients.289 But,
in 2006 (the inception of OARRS), the average time needed to run a report on a
patient was 30 seconds.290 By 2011, the time had decreased to just 3 seconds per
request.291 In fact, the State Board of Pharmacy has noted in their report to the Ohio
legislature, after the enactment of H.B. 93, that when OARRS users complain of the
difficulty in accessing OARRS most of their complaints stem from user errors, such
as: difficulty connecting to the internet, difficulty logging on to the website, and
other technical issues, such as the speed of the user’s computer or the network
speed.292 In order to address some of these shortcomings, the Ohio Board of
Pharmacy has begun working with two large pharmacy systems to see if OARRS
can be integrated into both the workflow and software of the user’s system.293
Some physicians are concerned with the administrative burden of referencing an
online patient database before prescribing a medication to a patient. 294 This criticism
is moot, however, because House Bill 93 grants medical support professionals the
ability to access OARRS.295 Further, the Ohio Board of Pharmacy has reported that
now 99.5% of requested reports process in less than three seconds.296 Others
maintain that such an online database is unnecessary because physicians are in the
best position to evaluate their patients and determine what medications, if any, are in

prescription is filled and when that activity actually appears in the database.”); Tribble, supra
note 113 (arguing reporting “would hit doctors at a time when they are seeing more patients
and implementing their own electronic medical records. Doctors receive training on what to
look for and how to evaluate potential patients who are doctor shopping for dangerous pain
medications. . .”).
288
See Sharon Woods Harris, Drug Databases Raises Privacy Concerns, PEKIN TIMES
(Mar. 14, 2009 10:00 AM), http://www.pekintimes.com/news/x679797701/Drug-databaseraises-privacy-concerns; see also Bill Sizemore, Hacking of Prescription Database May Lead
to Headaches, THE VIRGINIAN PILOT (May 8, 2009), available at http://web.archive.org/web
/20100213023552/http://www.pekintimes.com/news/x679797701/Drug-database-raisesprivacy-concerns.
289

Zimmer, supra note 20.
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OHIO STATE BOARD OF PHARMACY, supra note 22.
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OHIO STATE BOARD OF PHARMACY, supra note 22.

292

OHIO STATE BOARD OF PHARMACY, supra note 22.
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OHIO STATE BOARD OF PHARMACY, supra note 22.
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Tribble, supra note 113.
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See OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011) (providing agents of the
prescriber the ability to request reports from OARRS); see supra Part III.A (describing
positive changes of H.B. 93, one of which is to provide OARRS access to medical support
staff).
296

See Winsley & Droz, supra note 234.
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their patient’s best interest.297 OARRS does not retroactively prescribe medication
for a patient, but instead only gives additional information to physicians to make
better, more informed choices.298
Some critics of the online database are also concerned with storing personal
medical information on a central database and the accompanying vulnerability of
patients’ privacy.299 These critics point to various issues, including a patient’s right
to disclose personal medical information and the external threat of hackers.300 As to
the first issue, some patients wish to compartmentalize their personal medical
information.301 For example, patients may not be comfortable with a specialist
accessing their complete prescription medical history over a two-year period, which
may include problems unrelated to the patient’s treatment.302 This concern to keep
information private, however, does not justify the risks. On a micro level,
physicians need all relevant information about their patients’ medical history,
including a list of the medications they are taking, to provide the best care
compatible with the patient’s prior treatments and medications. On a macro level,
ending PMPs because some patients may not want physicians to know what
medications they are taking intensifies the problems with our current system in
which physicians are unable to determine the breathe of medications their patients
are taking.
Critics also cite computer hackers as another privacy concern.303 These critics
point to the Virginia pharmacy database security breach as a worst-case scenario.304
In Virginia, a hacker accessed the state’s online patient database and copied eight
million entries on personal medical information.305 The hacker then deleted the
Virginia database, and subsequently encrypted the copy that he kept for himself,

297

Tribble, supra note 113 (“Doctors receive training on what to look for and how to
evaluate potential patients who are doctor shopping for dangerous pain medications.”).
298

STATE MEDICAL BOARD OF OHIO, IMPROVING PATIENT CARE THROUGH ENHANCED USE
OF OARRS 1, available at https://www.ohiopmp.gov/Portal/images/MedBoardArticle.pdf
(“OARRS prescription history reports are an important component of delivering and
coordinating patient-centered care . . . Prescription history reports . . . assist providers in better
management of a patient’s prescription regimen . . .”).
299

See Harris, supra note 288; Sizemore, supra note 288.
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See Harris, supra note 288; see also Sizemore, supra note 288 (a group of legislators
asked the Florida governor to veto a new prescription database, citing the Virginia incident).
301

See generally Harris, supra note 288. Although this Article discusses privacy in the
context of law enforcement access to a prescription database, patients may be similarly
apprehensive to allow other healthcare professionals to access the database.
302

See Harris, supra note 288.
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See Sizemore, supra note 288.
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See Sizemore, supra note 288.
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Ira Winkler, The Virginia PMP Hack: ‘Burn After Reading’, INTERNET EVOLUTION,
(May 13, 2009), http://www.internetevolution.com/author.asp?section_id=515&doc_id
=176649; Bryan Boughton, et al, FBI Probes Hacker's $10 Million Ransom Demand for
Stolen Virginia Medical Records, FOXNEWS.COM (May 7, 2009), http://www.foxnews.
com/story/0,2933,519187,00.html.
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preventing the state from obtaining the information.306 The hacker finally posted a
ransom note, demanding $10 million for the password to decrypt the database.307
While the situation in Virginia was unfortunate, it was also preventable. First,
the prescription database was not encrypted.308 If this file had been encrypted, risks
would have been mitigated because most hackers could not have easily opened the
file the hacker in Virginia downloaded.309 Also, storing copies of the database
offsite would mitigate the damage caused by hackers attacking the website.310 As
soon as the database is taken offline, it can be restored through a comprehensive
disaster-recovery plan.311 Fortunately, Virginia maintained database copies, and it
was brought back online within a few days.312 Such precautionary measures
demonstrate that prescription databases, such as OARRS, can be safe tools when the
proper security measures are put in place.
As demonstrated above, there are many tenable concerns with implementing a
centralized database to store patient prescription information.313 While the risks are
note-worthy, such risks do not justify continuing to permit prescribers to exercise
discretion in deciding whether to run reports. Further, some criticisms are no longer
an issue after the enactment of H.B. 93 and the solution this Note proposes.314
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Finally, privacy issues regarding hackers can be mitigated with proper security
measures, as shown in Virginia case.315 Accordingly, Ohio needs to embrace
OARRS as a tool to combat prescription abuse, instead of vilifying it as a source of
liability.
IV. CONCLUSION
Prescription medications undoubtedly have an essential role in healthcare. As
demonstrated by the recent prescription abuse epidemics in Portsmouth, Ohio and
heroin deaths in Ohio’s suburbs, these medications are still dangerous, can lead to
the abuse of more serious drugs, and should be treated with the respect they
deserve.316 Thus, Ohio should mandate the use of OARRS reporting by all
physicians, increase the capacity of OARRS to interact with prescription databases
from other states, better promote drug “take back” programs, and enact stronger antidoctor shopper statutes.317 While these ideas are not a panacea to curbing all
prescription drug abuse, it will force the gatekeepers of controlled medications to
think twice before they dispense medications. Implementing these initiatives will
provide physicians the information necessary to make educated decisions about the
best medications to prescribe their patients. Additionally, these changes will remove
dangerous prescriptions from the streets, which inevitably lead to the slippery slope
of more serious illicit drug abuse.318 These solutions will restrict the home and
physician’s offices as major sources of prescription drugs, and thus help contain the
problems of prescription drug abuse.
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